<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Gut Microbes</journal-id>
<journal-id journal-id-type="iso-abbrev">Gut Microbes</journal-id>
<journal-id journal-id-type="publisher-id">KGMI</journal-id>
<journal-id journal-id-type="publisher-id">kgmi20</journal-id>
<journal-title-group>
<journal-title>Gut Microbes</journal-title>
</journal-title-group>
<issn pub-type="ppub">1949-0976</issn>
<issn pub-type="epub">1949-0984</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31368397</article-id>
<article-id pub-id-type="pmc">7053956</article-id>
<article-id pub-id-type="publisher-id">1638722</article-id>
<article-id pub-id-type="doi">10.1080/19490976.2019.1638722</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health</article-title>
<alt-title alt-title-type="running-authors">A. PARKER ET AL.</alt-title>
<alt-title alt-title-type="running-title">GUT MICROBES</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Parker</surname>
<given-names>Aimée</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="FT0001">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fonseca</surname>
<given-names>Sonia</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="FT0001">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carding</surname>
<given-names>Simon R.</given-names>
</name>
<xref ref-type="corresp" rid="AN0001"></xref>
<xref ref-type="aff" rid="AFF0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="AFF0002">
<sup>b</sup>
</xref>
</contrib>
<aff id="AFF0001"><label>a</label><institution>Gut Microbes and Health Research Programme, Quadram Institute Bioscience</institution>, Norwich, <country>UK</country></aff>
<aff id="AFF0002"><label>b</label><institution>Norwich Medical School, University of East Anglia</institution>, Norwich, <country>UK</country></aff>
</contrib-group>
<author-notes>
<corresp id="AN0001">CONTACT Simon R. Carding <email xlink:href="Simon.Carding@Quadram.ac.uk">Simon.Carding@Quadram.ac.uk</email><institution>Gut Microbes and Health Research Programme, Quadram Institute Bioscience, Norwich Research Park</institution>, Norwich NR4 7UA, <country>UK</country></corresp>
<fn id="FT0001">
<label>*</label>
<p>Equal contribution</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>8</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>11</volume>
<issue>2</issue>
<fpage seq="1">135</fpage>
<lpage>157</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 The Author(s). Published with license by Taylor &amp; Francis Group, LLC.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>The Author(s)</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="kgmi-11-02-1638722.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>The human gastrointestinal (gut) microbiota comprises diverse and dynamic populations of bacteria, archaea, viruses, fungi, and protozoa, coexisting in a mutualistic relationship with the host. When intestinal homeostasis is perturbed, the function of the gastrointestinal tract and other organ systems, including the brain, can be compromised. The gut microbiota is proposed to contribute to blood-brain barrier disruption and the pathogenesis of neurodegenerative diseases. While progress is being made, a better understanding of interactions between gut microbes and host cells, and the impact these have on signaling from gut to brain is now required. In this review, we summarise current evidence of the impact gut microbes and their metabolites have on blood-brain barrier integrity and brain function, and the communication networks between the gastrointestinal tract and brain, which they may modulate. We also discuss the potential of microbiota modulation strategies as therapeutic tools for promoting and restoring brain health.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>Microbiota</kwd>
<kwd>gut-brain axis</kwd>
<kwd>metabolites</kwd>
<kwd>blood-brain barrier</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<named-content content-type="funder-name">Biotechnology and Biological Sciences Research Council</named-content>
<named-content content-type="funder-identifier">10.13039/501100000268</named-content>
</funding-source>
<award-id>BB/J004529/1</award-id>
</award-group>
<award-group>
<funding-source>
<named-content content-type="funder-name">Biotechnology and Biological Sciences Research Council</named-content>
<named-content content-type="funder-identifier">10.13039/501100000268</named-content>
</funding-source>
<award-id>BB/R012490/1</award-id>
</award-group>
<award-group>
<funding-source>
<named-content content-type="funder-name">Biotechnology and Biological Sciences Research Council</named-content>
<named-content content-type="funder-identifier">10.13039/501100000268</named-content>
</funding-source>
<award-id>BBS/E/F000PR10355</award-id>
</award-group>
<award-group>
<funding-source>
<named-content content-type="funder-name">Fundación Alfonso Martín Escudero</named-content>
<named-content content-type="funder-identifier">10.13039/100008052</named-content>
</funding-source>
<award-id>Fellowship</award-id>
</award-group>
<funding-statement>This work was supported by the Biotechnology and Biological Sciences Research Council [BB/J004529/1, BB/and BBS/E/F000PR10355] and Fundación Alfonso Martín Escudero [Postdoctoral Fellowship].</funding-statement>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<ref-count count="223"></ref-count>
<page-count count="23"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S0001" sec-type="intro">
<title>Introduction</title>
<p>The gut microbiota play an essential role in the functioning of many organs in the body, including the brain. Our understanding of the composition and metabolism of the diverse ecosystem populating the gut, and the complex communication networks comprising the gut-brain axis are rapidly increasing in hand with advances in high-throughput ‘omics-based technologies. This review summarises findings linking the gut microbiota and brain health, with a focus on the impact of gut microbes, and the metabolites they generate from dietary components, on blood-brain barrier integrity. We discuss how these metabolites travel throughout the body along bidirectional neural and circulatory routes, from the perspective of the current knowledge of specific mechanisms. We also highlight the potential therapeutic potential on brain health of manipulating the gut microbiota via delivery of prebiotics, probiotics, and fecal microbiota transplantation. Such approaches can be effective in treating gastrointestinal disorders, and while their suitability and efficacy to treat neurological and neurodegenerative conditions require investigation, they are promising tools that may open unexplored routes to disease treatment and prevention through precise microbiome-targeted therapies.</p>
</sec>
<sec id="S0002">
<title>The intestinal microbiota in health and neurodegenerative diseases</title>
<p>The human microbiota consists of a diverse and dynamic population of microbes, including bacteria, archaea, viruses, fungi, and protozoa, that establish a mutualistic relationship with the host. More than 10<sup>14</sup> bacteria cells populate the gastrointestinal (GI) tract the vast majority of which (10<sup>10</sup>–10<sup>12</sup> CFU/g of intestinal content) are located in the ileum and colon.<sup><xref rid="CIT0001">1</xref></sup><sup><xref rid="CIT0002">2</xref></sup> A taxonomically diverse intestinal microbiota is associated with integrity of the epithelial barrier, and maintenance of intestinal metabolic and immune homeostasis. Some species of <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> genera are considered beneficial, with the presence of <italic>Lactobacillus rhamnosus</italic>, for example, associated with increased intestinal barrier function and expression of epithelial tight junction proteins, and decreased serum levels of inflammatory cytokines.<sup><xref rid="CIT0003">3</xref></sup> By comparison, overgrowth of <italic>Clostridium</italic> is often a feature of intestinal microbial dysbiosis and increased intestinal permeability (“leaky gut syndrome”), a feature of inflammatory bowel diseases and other immune-related intestinal and extra-intestinal disorders.<sup><xref rid="CIT0004">4</xref></sup> Beyond the GI-tract, the microbiota may also play a role in the functioning of other organ systems including the brain.<sup><xref rid="CIT0005">5</xref></sup> Evidence for the GI-microbiota influencing the brain comes primarily from animal studies, in particular germ-free rodents, in which structural and functional attributes of the brain can be assessed prior to, and after, microbial exposure and colonization. The absence of gut microbes is associated with structural alterations in the blood-brain barrier (BBB), characterized by decreased expression of tight junction proteins, leading to increased permeability compared to conventional-specific pathogen free (SPF) mice.<sup><xref rid="CIT0006">6</xref></sup> Of note, conventionalizing germ-free mice using fecal material from SPF mice, decreases the permeability of the BBB,<sup><xref rid="CIT0006">6</xref></sup> providing evidence of a causal relationship between gut microbes and BBB integrity. Related experiments using chronically-administered antibiotics to deplete the gut microbiota in mice resulted in object recognition impairment<sup><xref rid="CIT0007">7</xref></sup> and decreased hippocampal neurogenesis and memory retention, which were reversed by administering probiotic bacteria.</p>
<p>Recent studies suggest the gut microbiota may contribute to the development or progression of neurodegenerative diseases and dementia. Neurodegenerative diseases are characterized by impaired motor function and/or dementia, which is one of the major causes of disability and dependency among older people worldwide.<sup><xref rid="CIT0008">8</xref></sup> Dementia is a collection of symptoms used to categorize and diagnose the disease type. Common forms include Alzheimer’s disease (AD), vascular dementia, frontotemporal dementia, Parkinson’s disease (PD), and dementia with Lewy bodies; all are chronic or progressive in nature and feature deterioration in memory, thinking, behavior, and the ability to perform everyday activities. A common feature of all dementias is chronic neuroinflammation, involving overactivation and dysregulation of microglia,<sup><xref rid="CIT0009">9</xref></sup> the resident macrophage-like immune cells of the brain. When microglia are activated, their morphology changes in association with increased secretion of pro-inflammatory cytokines, such as IFN-γ, IL-6, and TNF-α, and the release of reactive oxygen and nitrogen species,<sup><xref rid="CIT0010">10</xref></sup> which can lead to neuronal cell death, loss of BBB integrity, and brain damage. Whether changes in BBB integrity are a cause or a consequence of neuroinflammation in patients is a major unresolved question.<sup><xref rid="CIT0011">11</xref></sup> This central question has been approached using animal models and, in particular, genetically modified mice which develop features of AD or PD. Transgenic mice expressing the amyloid-β precursor protein (APP) develop fewer cerebral β-amyloid plaques when maintained under germ-free conditions compared to conventionalized mice.<sup><xref rid="CIT0012">12</xref></sup> Consistent with this finding, and supporting a role for the gut microbiota in the pathogenesis of neuroinflammation in this mouse model, antibiotic administration also limits β-amyloid pathology and neuroinflammation.<sup><xref rid="CIT0013">13</xref></sup> Possible links between specific commensal bacteria and neuroinflammation have been identified from microbiota taxonomic profiling in PD patients with alterations in populations of potentially beneficial bacteria (e.g. <italic>Prevotella</italic> genus) and pathogenic bacteria (e.g. members of the Enterobacteriaceae family).<sup><xref rid="CIT0014">14</xref>,<xref rid="CIT0015">15</xref></sup> Although these findings are intriguing and implicate the gut microbiota in neuroinflammation, they and other related studies have, to date, provided limited mechanistic insight and have been unable to identify the pathways by which gut microbes can influence, directly or indirectly, the BBB.</p>
</sec>
<sec id="S0003">
<title>The blood-brain barrier</title>
<p>The term “blood-brain barrier” was first coined by Stern and Gautier,<sup><xref rid="CIT0016">16</xref></sup> who examined the penetration or exclusion of compounds, such as morphine or India ink, between blood and brain, and proposed a role for the barrier in maintaining brain homeostasis. Later studies in the 1960s demonstrated that the BBB was located in the endothelium forming the walls of vessels in the brain.<sup><xref rid="CIT0017">17</xref>,<xref rid="CIT0018">18</xref></sup> Since these pioneering studies, the concept of the BBB as a static, impermeable barrier has evolved into the current view of a dynamic, highly regulated, specific cellular system,<sup><xref rid="CIT0019">19</xref></sup> with increasing awareness of the contribution multiple cell types play in regulating dynamic BBB responses. The BBB is now considered to be part of a neurovascular unit (NVU) (<xref rid="F0001">Figure 1</xref>) comprising brain microvascular endothelial cells (BMEC), pericytes, astrocytes, neurons, microglia, and extracellular matrix (ECM),<sup><xref rid="CIT0020">20</xref></sup> which together contribute to regulating BBB stability and function. This organization is found in all brain regions, except for the circumventricular organs, which regulate the autonomic nervous system and endocrine glands and have fenestrations allowing the diffusion of molecules across vessel walls.<sup><xref rid="CIT0021">21</xref></sup><fig fig-type="figure" id="F0001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1080/19490976.2019.1638722-F0001</object-id><label>Figure 1.</label><caption><p>Schematic representation of the human blood-brain-barrier neurovascular-endothelial-unit in health (a) and disease (b) states. Increased permeability related to, for example trauma or infection, is associated with disruption of endothelial tight junctions leading to the ingress and translocation of blood-borne immune cells, and inflammatory mediators such as cytokines and microbes and their products that can activate microglia, resulting in local inflammation leading to loss of extracellular matrix and astrocyte, pericyte and neuronal cell dysfunction and death.</p></caption><graphic content-type="color" xlink:href="kgmi-11-02-1638722-g001"></graphic></fig></p>
<p>BMECs are interconnected by protein complexes consisting of highly electrically-resistant tight junctions (<italic>zonulae occludens</italic>), which limit the paracellular flow of molecules between adjacent endothelial cells to maintain ionic homeostasis in the brain.<sup><xref rid="CIT0022">22</xref></sup> Joining the BMECs are several non-endothelial cells including pericytes that wrap around the capillary endothelium<sup><xref rid="CIT0023">23</xref></sup> and can modify vascular diameter and regulate transcytosis and immune cell trafficking across the BBB.<sup><xref rid="CIT0024">24</xref></sup> Astrocytes and their endfeet form a second physical, transport, and metabolic barrier around pericytes and endothelial cells, and communicate with neurons to establish an endothelium-neuron link.<sup><xref rid="CIT0025">25</xref></sup> Pericytes and astrocytes also transmit neuronal signals to the local vasculature, affecting barrier physiology by altering arteriolar dilation and blood flow.<sup><xref rid="CIT0026">26</xref></sup> While implicated in the regulation of vascular growth during angiogenesis, the role of microglia in homeostatic BBB maintenance is not clear, but these cells are major players in the inflammation associated with neurodegenerative diseases, secreting pro-inflammatory cytokines and factors promoting BBB breakdown and neuronal loss. In inflammatory states, remodeling of BMEC tight junctions increases transcellular permeability, allowing circulating inflammatory cytokines and effectors into the brain. Inflammatory activation of vascular endothelium can induce BMEC expression of adhesion molecules and chemoattractants, allowing infiltration of neutrophils and effector Th1 and Th17 subsets of CD4<sup>+</sup> T cells which are implicated in the pathogenesis of multiple sclerosis (MS), AD and PD.<sup><xref rid="CIT0027">27</xref>,<xref rid="CIT0028">28</xref></sup> Astrocyte morphology and secretion of inflammatory cytokines and chemoattractants are altered in early stages of AD pathology.<sup><xref rid="CIT0026">26</xref></sup> Amyloid-β protein can induce BMEC activation and tight junction remodeling, and pericyte damage and loss leads to cognitive impairment, increased amyloid-β deposition, and tau pathology.<sup><xref rid="CIT0029">29</xref></sup> In summary, a combination of inflammation and changes in BBB component cell functions contribute to neurodegenerative disease-associated BBB breakdown. Infiltrating immune cells, microglial cells, and astrocytes may reciprocally activate each other, driving chronic inflammation and preventing BBB repair, with pericyte damage and neuronal loss further promoting cognitive decline. Preserving and restoring BBB integrity therefore presents a primary target for developing neuroprotective strategies and interventions.</p>
</sec>
<sec id="S0004">
<title>Gut microbiota-derived metabolites influencing BBB integrity and brain health</title>
<p>The gut microbiota transform dietary components, including macro- and micronutrients, fibs, and polyphenols, into a range of metabolites, including short-chain fatty acids, trimethylamines, amino acid derivatives, and vitamins. These microbial-derived metabolites and dietary components have essential metabolic and signaling functions which can modulate host homeostasis, including BBB integrity and brain function. Microbial metabolites affecting the BBB and brain are detailed below, and specific studies describing effects of some of these metabolites on BBB permeability are summarised in <xref rid="T0001">Table 1</xref>.
<table-wrap id="T0001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1080/19490976.2019.1638722-T0001</object-id><label>Table 1.</label><caption><p>Effects of gut microbes and their metabolites on blood-brain barrier permeability.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col align="left" width="1*"/><col align="left" width="1*"/><col align="left" width="1*"/><col align="left" width="1*"/><col align="center" width="1*"/></colgroup><thead><tr><th align="left">Method</th><th align="center">Permeability modulator</th><th align="center">Model</th><th align="center">Effects on BBB</th><th align="center">Reference</th></tr></thead><tbody><tr><td align="left"><italic>In vivo</italic></td><td align="left"><italic>Clostridium butyricum</italic></td><td align="left">Traumatic brain injury on C57Bl/6 mice</td><td align="left">↑ TJ proteins expression<break></break>↓ Permeability</td><td align="center"><sup><xref rid="CIT0030">30</xref></sup></td></tr><tr><td align="left"> </td><td align="left"><italic>Clostridium tyrobutyricum</italic>,<break></break><italic>Bacteroides thetaiotaomicron</italic> and sodium butyrate</td><td align="left">Germ-free C57Bl/6 mice</td><td align="left">↑ TJ proteins expression<break></break>↓ Permeability</td><td align="center"><sup><xref rid="CIT0006">6</xref></sup></td></tr><tr><td align="left"> </td><td align="left">Sodium butyrate</td><td align="left">Traumatic brain injury on C57Bl/6 mice</td><td align="left">↑ TJ proteins expression<break></break>↓ Permeability</td><td align="center"><sup><xref rid="CIT0031">31</xref></sup></td></tr><tr><td align="left"> </td><td align="left">Acetate/propionate/butyrate</td><td align="left">α-synuclein overexpressing germ-free BDF1 mice</td><td align="left">↑ Microglia activation</td><td align="center"><sup><xref rid="CIT0015">15</xref></sup></td></tr><tr><td align="left"> </td><td align="left">Chenodeoxycholic acid and deoxycholic acid</td><td align="left">Bile duct ligation on Sprague Dawley rats</td><td align="left">↑ Permeability</td><td align="center"><sup><xref rid="CIT0032">32</xref></sup></td></tr><tr><td align="left"><italic>In vitro</italic></td><td align="left">Propionate</td><td align="left">hCMEC/D3 treated with LPS</td><td align="left">↓ Paracellular permeability<break></break>↑ TEER</td><td align="center"><sup><xref rid="CIT0033">33</xref></sup></td></tr><tr><td align="left"> </td><td align="left">Chenodeoxycholic acid and deoxycholic acid</td><td align="left">RBMECs</td><td align="left">↑ Permeability</td><td align="center"><sup><xref rid="CIT0032">32</xref></sup></td></tr></tbody></table></table-wrap>
</p>
<p><bold><italic>Short Chain Fatty Acids (SCFA</italic></bold>): are small organic monocarboxylic acids, principally produced by colonic fermentation of dietary fib and complex plant-based polysaccharides, to generate energy and release carbon, permitting microbial growth. SCFAs are present at an approximate concentration of 100 mM in the colonic lumen at a ratio of 60:25:15 for acetate:propionate:butyrate, respectively.<sup><xref rid="CIT0034">34</xref></sup> The production of propionate is primarily restricted to members of the Clostridiales order of anaerobic bacteria, with production of acetate and butyrate being more broadly distributed.<sup><xref rid="CIT0035">35</xref></sup> Over 95% of SCFAs produced in the colon are absorbed by the mucosa of healthy individuals<sup><xref rid="CIT0036">36</xref></sup> with all three detectable in the peripheral blood at ratios different to those in the lumen (acetate, 22–42 μM; propionate, 0.9–1.2 μM; butyrate, 0.3–1.5 μM).<sup><xref rid="CIT0033">33</xref></sup> SCFAs stimulate colonic blood flow, upper-gut motility, influence water and salt uptake, and enhance satiety.<sup><xref rid="CIT0036">36</xref></sup> They can also access the BBB via the bloodstream to impact directly on its integrity.<sup><xref rid="CIT0037">37</xref></sup> For example, BBB permeability decreases in germfree mice after colonization with the butyrate producer <italic>Clostridium tyrobutyricum</italic> or, after oral administration of sodium butyrate, by upregulating tight junction proteins.<sup><xref rid="CIT0006">6</xref></sup> Following traumatic brain injury, intravenous or intraperitoneal administration of sodium butyrate can prevent BBB breakdown and promote neurogenesis.<sup><xref rid="CIT0030">30</xref>,<xref rid="CIT0031">31</xref>,<xref rid="CIT0038">38</xref></sup> It is therefore conceivable that modulating SCFA levels could be useful in preventing or treating neural decline. Intraperitoneal administration of butyrate or increased dietary soluble fib (inulin) intake improve neuroinflammation in aging mice,<xref rid="CIT0039"><sup>39</sup></xref> and in CK-p25 transgenic mice, which exhibit synaptic and neuronal loss and learning, intracerebroventricular injections of butyrate modify histone acetylation in the hippocampus to improve memory and learning.<sup><xref rid="CIT0040">40</xref></sup> Protective, anti-inflammatory, and permeability-reducing effects of propionate treatment have also been described in a human brain endothelial cell culture model.<sup><xref rid="CIT0033">33</xref></sup> On the other hand, high brain levels of propionate can exacerbate symptoms in a mouse model of autism, but this can be mitigated with butyrate supplementation,<xref rid="CIT0041"><sup>41</sup></xref> suggesting metabolite balance rather than individual metabolite levels may be important. The maturation of microglial cells, which regulate BBB integrity, neuroinflammation, and neurogenesis, is modified by SCFA in germfree mice, where the reduced microglia number, function and morphology can be rescued by 4-week delivery of an SCFA cocktail in drinking water.<sup><xref rid="CIT0042">42</xref></sup> Pending clinical trials on specific-optimized SCFA supplementations, it has been hypothesized that providing SCFA mixtures or simply increasing dietary fib could rescue the hypometabolism associated with neuronal dysfunction in neurodegenerative conditions including AD.<sup><xref rid="CIT0043">43</xref></sup> Intriguingly, a handful of recent studies in which bacterial, viral, and fungal-derived nucleic acids and proteins have been detected in post-mortem brains of AD sufferers<sup><xref rid="CIT0044">44</xref>,<xref rid="CIT0045">45</xref></sup> suggest microbial metabolites such as SCFAs could be produced locally, by brain-resident or infiltrating microbes. The possibility of a ‘brain microbiome’ remains controversial, but while consideration of possible contamination issues is needed in interpreting the detection of nucleic acids from low-abundance microbes in tissue samples, Carrasco and colleagues<sup><xref rid="CIT0046">46</xref>-<xref rid="CIT0048">48</xref></sup> provide supporting immunostaining data for various fungal species in post-mortem brain tissue from Alzheimer’s patients. These included <italic>Candida albicans,</italic> which is commonly found in the mammalian gut but more rarely isolated from the environment,<sup><xref rid="CIT0049">49</xref>,<xref rid="CIT0050">50</xref></sup> and the detection of both budding and hyphal forms,<sup><xref rid="CIT0047">47</xref>,<xref rid="CIT0048">48</xref></sup> indicative of fungal growth within the living tissue. Whilst gut microbes can dictate the metabolite availability within the intestine and the brain via the circulation, whether they have a significant impact on SCFA availability within the brain as ‘local’ residents remains to be determined. Additional work is now needed to understand the optimum balance of SCFAs in the periphery and the brain which promote healthy aging, and further still how the microbiome of the gut (and potentially the brain) can be manipulated to achieve this balance and protect cognitive health.</p>
<p><bold><italic>Trimethylamines</italic></bold>: are metabolites produced from gut microbial metabolism of dietary choline, lecithin, carnitine and trimethylamine-N-oxide (TMAO) that are present in foods such as eggs, nuts, dairy products, meat, and fish. Choline is degraded into trimethylamine (TMA), which is converted in the liver by flavin-containing monooxygenases (FMOs) into TMAO, and demethylated into dimethylamine and methylamine.<sup><xref rid="CIT0051">51</xref></sup> Gut-derived TMA is generated by bacteria of the genera <italic>Anaerococcus, Clostridium, Escherichia, Proteus, Providencia</italic>, and <italic>Edwardsiella</italic>.<sup><xref rid="CIT0052">52</xref></sup> The presence of TMAO in human brains indicates its ability to cross the BBB.<sup><xref rid="CIT0053">53</xref></sup> TMAs have been associated with both beneficial and detrimental health effects. High plasma levels of TMAO have been associated with increased risk of colorectal cancer<sup><xref rid="CIT0054">54</xref></sup> and with risk of developing atherosclerosis and cardiovascular disease via effects on cholesterol metabolism.<sup><xref rid="CIT0055">55</xref></sup> This is of interest regarding neurodegenerative diseases including AD and vascular dementia, in which cardiovascular disease and altered cholesterol metabolism are strongly associated with increased risk. In individuals with a hereditary defect in FMO3, bacterial TMA production contributes to the symptoms of trimethylaminuria (TMAU) or fish-odor syndrome.<sup><xref rid="CIT0056">56</xref></sup> Therapy with archaebiotics and attempting to modulate the gut microbiota by administering specific strains of TMA metabolizing Archaea has been proposed as a treatment for cardiovascular diseases and TMAU. The methanogen, <italic>Methanomassiliicoccales</italic> can reduce TMA concentration in the gut by converting it to methane, thus decreasing the production of TMAO from TMA in the liver.<sup><xref rid="CIT0057">57</xref>,<xref rid="CIT0058">58</xref></sup> TMAO’s beneficial effects include reducing endoplasmic reticulum stress and lipogenesis in adipocytes, increasing insulin secretion in pancreatic islets, and attenuating diet-induced impaired glucose tolerance.<sup><xref rid="CIT0059">59</xref>,<xref rid="CIT0060">60</xref></sup> Again, by extension, such therapies may also be beneficial in protecting against neurodegenerative disease as diabetes which is another dementia-associated risk-factor. More specific to AD, TMAO has also been shown to restore the ability of mutant tau protein to promote microtubule assembly<sup><xref rid="CIT0061">61</xref>,<xref rid="CIT0062">62</xref></sup> with microtubule disassembly and neuron death being hallmark pathological features of AD.<sup><xref rid="CIT0063">63</xref></sup> In addition to its potential use as an AD biomarker,<sup><xref rid="CIT0064">64</xref></sup> TMAO may also have a therapeutic effect in AD and other protein-misfolding conditions, by preferentially hydrating partially denatured proteins to correct folding defects and entropically stabilizing native conformations.<sup><xref rid="CIT0065">65</xref>,<xref rid="CIT0066">66</xref></sup></p>
<p><bold><italic>Amino acid metabolites</italic></bold>: the gut microbiota plays an essential role in amino acid catabolism the products of which can influence the balance between the production of excitatory and inhibitory neurotransmitters essential for correct brain functioning.<sup><xref rid="CIT0067">67</xref></sup> Species of the genera <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> metabolize glutamate, the most abundant free amino acid and excitatory neurotransmitter in the brain, to produce γ-aminobutyric acid (GABA), a major inhibitory neurotransmitter.<sup><xref rid="CIT0068">68</xref></sup> Decarboxylases secreted by <italic>Clostridium sporogenes</italic> contribute to converting tryptophan, an essential amino acid found in a wide range of foods,<sup><xref rid="CIT0069">69</xref></sup> to the neurotransmitter tryptamine, involved in the release of serotonin by cells of the enteroendocrine and enteric nervous systems.<sup><xref rid="CIT0070">70</xref>,<xref rid="CIT0071">71</xref></sup> Germfree mice display increased plasma tryptophan levels, which are normalized after conventionalization.<sup><xref rid="CIT0072">72</xref></sup>
<italic>Bifidobacterium infantis</italic> can increase plasma levels of tryptophan.<sup><xref rid="CIT0073">73</xref></sup> Bacterial conversion of tryptophan to indoles, ligands for aryl hydrocarbon receptor (AHR), can decrease brain inflammation and limit disease severity in murine models of MS by activating astrocytes.<sup><xref rid="CIT0074">74</xref></sup> Tryptophan is a precursor of many other diverse microbial and host metabolites<sup><xref rid="CIT0075">75</xref></sup> including kynurenic acid, which has anti-inflammatory properties in the gastrointestinal tract<sup><xref rid="CIT0076">76</xref></sup> and is considered to be neuroprotective,<sup><xref rid="CIT0077">77</xref></sup> and quinolinic acid, which is a neurotoxin and a BBB modulator implicated in the etiology of psychiatric disorders and neurodegenerative diseases.<sup><xref rid="CIT0078">78</xref>,<xref rid="CIT0079">79</xref></sup> Tryptophan and glutamate-metabolizing microbes may therefore perform important BBB and brain-protective functions, but greater understanding and care are needed to harness their therapeutic potential while avoiding the effects of potentially harmful derivatives.</p>
<p><bold><italic>Vitamins</italic></bold>: are essential micronutrients which humans must obtain from their diet and intestinal microbiota. Vitamin K is produced by <italic>Escherichia coli, Klebsiella pneumoniae, Propionibacterium</italic>, and <italic>Eubacterium</italic>; B2 (riboflavin) by <italic>Bacillus subtilis</italic> and <italic>E. coli</italic>; B9 (folic acid) by <italic>Bifidobacterium, Lactococcus lactis</italic> and <italic>Streptococcus thermophilus</italic>; and B12 (cobalamin) by <italic>Lactobacillus reuteri</italic> and <italic>Propionibacterium freudenreichii</italic>.<sup><xref rid="CIT0080">80</xref></sup> The uptake of microbe-derived vitamins occurs predominantly in the colon, in contrast to dietary vitamins, which are absorbed in the small intestine.<sup><xref rid="CIT0081">81</xref></sup> Vitamins have a variety of roles in maintaining and protecting intestinal and systemic health throughout life. Vitamin K, essential for the process of thrombosis,<sup><xref rid="CIT0082">82</xref></sup> is routinely administered to neonates shortly after birth to prevent hemorrhagic disease, prior to the establishment of their gut microbiota.<sup><xref rid="CIT0083">83</xref></sup> Low levels of vitamin K have been correlated with apolipoprotein Eϵ4 allele, a risk factor linked to AD.<sup><xref rid="CIT0084">84</xref></sup> Vitamin K has also been shown to have a beneficial role in the modulation of α-synuclein fibrillization, associated with PD.<sup><xref rid="CIT0085">85</xref></sup> Increased dietary vitamin K intake has been associated with less severe subjective memory complaints in the elderly.<sup><xref rid="CIT0086">86</xref></sup> Vitamin B synthesis increases as the intestinal microbiota are being established<sup><xref rid="CIT0087">87</xref></sup> with deficiencies leading to serious neurological disorders including beri-beri, polyneuropathy and cerebellar ataxia.<sup><xref rid="CIT0088">88</xref></sup> Vitamin B9 has a preventive role in the development of neural tube defects, coronary heart disease, cancer, and neuropsychiatric disorders.<sup><xref rid="CIT0089">89</xref></sup> Folate deficiency has been associated with depression, with methylfolate being one of the only medical foods licensed for treating depression.<sup><xref rid="CIT0090">90</xref>,<xref rid="CIT0091">91</xref></sup> Folate intake below the Recommended Daily Allowance may also increase the risk for mild cognitive impairment and probable dementia among older women.<sup><xref rid="CIT0092">92</xref></sup> Similarly, high-dose B-vitamin treatment, including B6, B9, and B12, can decrease levels of homocysteine, a by-product of vitamin B, and slow the atrophy of specific regions of the brain associated with cognitive decline in AD.<sup><xref rid="CIT0093">93</xref></sup></p>
<p>In summary, SCFAs and other microbial metabolites can act at the intestinal epithelial barrier, the blood-brain-barrier, directly on brain neurons, or by regulating the endocrine and immune systems to protect against the pathology and inflammation associated with ageing and disease, and may also protect against neurodegeneration by limiting the transit and influx of pathological microbes and their products into the brain.</p>
</sec>
<sec id="S0005">
<title>Pathways of communication along the microbiota-gut-brain axis</title>
<p>Intestinal metabolic health status is relayed to the brain by both neural and circulatory routes (<xref rid="F0002">Figure 2</xref>). Bidirectional gut-brain neural relays control satiety signaling and appetite regulation.<sup><xref rid="CIT0094">94</xref></sup> Detection of luminal metabolites by intestinal enteroendocrine cells is communicated to the brain via activation of the vagus nerve,<sup><xref rid="CIT0095">95</xref></sup> by epithelial cell-derived hormones and neurotransmitters,<sup><xref rid="CIT0096">96</xref>,<xref rid="CIT0097">97</xref></sup> and via neural routes, including neuroepithelial connections.<sup><xref rid="CIT0098">98</xref>,<xref rid="CIT0099">99</xref></sup> Dietary metabolites and epithelial-derived soluble factors may also travel via the bloodstream to the BBB, where a variety of nutrient transporters and specific receptors expressed on BMECs<sup><xref rid="CIT0100">100</xref>,<xref rid="CIT0101">101</xref></sup> facilitate the translocation of specific nutrients (e.g. glucose, lactate) across the barrier into the brain parenchyma, and allow for binding of circulating peptide hormones and other factors which can modulate brain activity. The microbial metabolites discussed above including SCFAs, TMAs, amino acid metabolites, and vitamins can travel via or modulate these pathways to affect enteroendocrine, neuronal, and immune cells in the gut, liver, kidneys, pancreas, and brain.<fig fig-type="figure" id="F0002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1080/19490976.2019.1638722-F0002</object-id><label>Figure 2.</label><caption><p>Pathways of communication along the gut-microbiota-brain axis. A complex interplay of epithelial, immune and neural cell signalling networks is involved in sensing and communicating changes in microbial metabolites in the gut and the brain involving both circulatory and neural routes.</p></caption><graphic content-type="color" xlink:href="kgmi-11-02-1638722-g002"></graphic></fig></p>
<sec id="S0005-S2001">
<title>Endocrine and neuroendocrine signaling</title>
<p>In the intestinal epithelium, specialized sensory enteroendocrine cells express a range of G-protein-coupled receptors (GPCR), transporters, and other receptors for fatty acids, carbohydrates, peptides, amino acids, and phytochemicals. Binding of bacterial products to these receptors induces the release of peptide hormones (including the incretin hormones GLP-1 and GIP, and neuropeptides CCK, PYY, and serotonin) which can act locally on enteric neurons, or enter the circulation and activate neurons innervating the portal vein, to signal to the brainstem via the vagus nerve. It is possible that some circulating hormones could reach and act directly on the brain. GLP-1 for example may be able to reach the brain either by crossing the blood-brain barrier<sup><xref rid="CIT0102">102</xref></sup> or by acting at circumventricular structures.<sup><xref rid="CIT0103">103</xref></sup> However, the short half-life of peptide hormones in the circulation,<sup><xref rid="CIT0104">104</xref></sup> the excitation of enteric neurons and the vagus in response to metabolites and gut hormones,<sup><xref rid="CIT0105">105</xref>,<xref rid="CIT0106">106</xref></sup> and the speed of responses to nutrients,<xref rid="CIT0107"><sup>107</sup></xref> reinforce the importance of neural signaling networks in communicating signals from the gut to the brainstem.<sup><xref rid="CIT0108">108</xref></sup> Enteric neurons express receptors for SCFAs<sup><xref rid="CIT0109">109</xref></sup> and bile acids<sup><xref rid="CIT0110">110</xref></sup> facilitating metabolite regulation of gastrointestinal motility<sup><xref rid="CIT0111">111</xref></sup> and allowing fast relay of information to the brain about metabolites crossing the epithelial barrier, and the concentrations of those metabolites in the gut lamina propria. For example, administration of luminal glucose activates both enteroendocrine cells and neural cells of the myenteric plexus, nodose ganglion and brainstem.<sup><xref rid="CIT0112">112</xref></sup></p>
<p>Recent studies reveal direct physical associations between the epithelium and enteric nerves. Some enteroendocrine cells exhibit ‘neuropod’ processes which directly synapse with local neural networks, forming ‘neuroepithelial units’ which can and transmit chemical and electrical signals in response to metabolite binding.<sup><xref rid="CIT0099">99</xref>,<xref rid="CIT0113">113</xref></sup> At present, the relative balance and importance of the circulatory, neural, and neuro-epithelial routes in relaying luminal information to the brain are unknown. Given the complexity within the gastrointestinal tract luminal environment, the summation and combination of all routes may be required to accurately convey varying spatiotemporal conditions and fluctuating microbial and metabolic states.</p>
<p>Encouragingly, the ability to map connectivity between neurons manipulate neural activity in real time, and measure neural activity during behavior has produced a wealth of data approaching a “wiring diagram” of the bidirectional gut-brain control of appetite, able to describe and predict the effects of dietary nutrients, common hormones and regulators.<sup><xref rid="CIT0094">94</xref></sup> Building on this, recent studies are attempting to connect altered bacterial metabolism to specific neural signaling affecting brain functions. For example, Schretter and colleagues<sup><xref rid="CIT0114">114</xref></sup> describe how locomotor hyperactivity in germfree Drosophila (manifested as increased walking speed and daily activity) can be rescued by altering sugar metabolism, either by colonization with <italic>L. brevis</italic> or by administration of <italic>L. brevis</italic>-derived xylose isomerase. The behavioral hyperactivity effect in germfree flies was shown to be mediated by octapaminergic neurons, as specific stimulation of these neurons or exogenous administration of octopamine (the invertebrate counterpart of noradrenaline) prevented the rescue by xylose isomerase.<sup><xref rid="CIT0114">114</xref></sup> In mouse models, <italic>in vivo</italic> cell-connectivity tracing and enteroendocrine-neural co-cultures have shown that glucose stimulation of CCK-positive enteroendocrine cells activates vagal nodose neurons by glutamate-based neurotransmission.<sup><xref rid="CIT0099">99</xref></sup> What impact this signaling might have on regulation of BBB integrity and neurodegenerative disease remains to be determined, but it is an exciting step forward in connecting specific gut epithelial-neural circuits and developing the necessary understanding to trace microbe-to-brain communication.</p>
</sec>
<sec id="S0005-S2002">
<title>Immune and neurotransmitter signaling</title>
<p>In addition to their actions on enteroendocrine and neural cells, metabolites can act via GPCR and other receptors to direct the development and normal functioning of the mucosal immune system; regulating the recruitment, development, maintenance, and activation of immune cells. The balance of dietary and bacterial metabolites is important for maintaining immune tolerance, and in directing inflammatory responses in the gut.</p>
<p>There are three main routes by which metabolite-immune cell interactions in the gut may be relayed to the brain. The first is via the secretion of cytokines and other immune signaling molecules into the bloodstream which ultimately reach the BBB. Breakdown of the epithelial barrier, resulting from dysbiosis, infection, damage, or age-associated degeneration allows ingress of bacteria, their metabolites, and other components such as toxins and lipopolysaccharides (LPS), triggering inflammatory immune responses and enteric neuronal damage.<sup><xref rid="CIT0115">115</xref></sup> If not resolved, continuous or remitting intestinal inflammation (a hallmark of inflammatory bowel disease) can promote a state of chronic systemic inflammation characterized by elevated serum TNF, IL-6, and IL-1β, disrupting the BBB by increasing the permeability of the BMEC layer<sup><xref rid="CIT0116">116</xref></sup> and allowing solutes and toxins into the brain. Increased systemic and brain inflammation also promotes immune cell extravasation<sup><xref rid="CIT0117">117</xref></sup> and stimulates inflammatory signalling by cells of the NVU and brain microglia,<sup><xref rid="CIT0118">118</xref></sup> perpetuating a vicious cycle of brain inflammation and neurodegeneration. <italic>In vivo</italic> infection models show that elevated TNF drives brain pathology in a Drosophila model of enterobacteria infection-aggravated AD.<sup><xref rid="CIT0119">119</xref></sup> In mice, blocking TNF uptake at the BBB by inhibiting TNF receptor 1 (TNFR1) can reduce immune cell infiltration and ameliorate disease severity in a model of MS.<sup><xref rid="CIT0120">120</xref></sup> Metabolite-immune cell interactions, intestinal barrier dysfunction, and bacterial infection can therefore be important early events in initiating neurodegenerative disease by altering gut-to-brain cytokine signaling and immune cell trafficking.</p>
<p>In the second route, metabolite induced secretion of immune cell cytokines and neurotransmitters may act locally on enteric neurons innervating the gut and alter vagus nerve signaling to the brain. With advancing age, a primary risk factor for neurodegenerative diseases, a shift in the polarisation of intestinal macrophages and their cytokine production alters enteric neural responses to inflammatory signals and increases apoptosis and loss of enteric neurons.<sup><xref rid="CIT0121">121</xref></sup> Loss of enteric neurons not only alters intestinal functions but has implications for the ability of the gut to communicate with the brain. Furthermore, the cytokine milieu affects the functioning of enteric glial cells that support and regulate enteric neuronal functions by production of glial cell-derived neurotrophic factors (GDNFs). Glial cell GDNF production in response to microbial-immune cell signaling,<sup><xref rid="CIT0122">122</xref></sup> and potentially via SCFA-GPCR activation,<sup><xref rid="CIT0123">123</xref>,<xref rid="CIT0124">124</xref></sup> induces innate lymphoid type 3 (ILC3) cells to produce IL-22, promoting protection and restoration of the epithelial barrier.<sup><xref rid="CIT0125">125</xref></sup> These cells are therefore important in integrating microbial and host signalling in neuro-immune responses in the intestinal mucosa.</p>
<p>Along with immunoregulatory cytokines, binding of bacterial metabolites to intestinal cells can also trigger the release of local peptide neurotransmitters, including PYY and serotonin, for which enteric neurons express specific receptors.<sup><xref rid="CIT0126">126</xref>,<xref rid="CIT0127">127</xref></sup> For example, decarboxylation of tryptophan to tryptamine by <italic>Clostridium sporogenes</italic> induces enterochromaffin cells to release serotonin, which acts on enteric neurons to stimulate gastrointestinal motility.<sup><xref rid="CIT0128">128</xref>,<xref rid="CIT0129">129</xref></sup>Serotonin is also involved in regulating neurogenesis during development<sup><xref rid="CIT0130">130</xref></sup> but detangling its role in adult neurodegeneration is complicated by the multitude of serotonin receptor subtypes expressed in the mammalian brain.<sup><xref rid="CIT0131">131</xref></sup> Gut microbes may also trigger neurotransmitter release via Toll-Like Receptor (TLR) signaling on epithelial, immune and neuronal cells.<sup><xref rid="CIT0132">132</xref>,<xref rid="CIT0133">133</xref></sup> Finally, bacterial metabolites may act directly as neurotransmitters, acting locally and in the brain. <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> can metabolize glutamate to produce GABA, a major inhibitory neurotransmitter of the brain<sup><xref rid="CIT0068">68</xref>,<xref rid="CIT0134">134</xref></sup> and modulator of gut functions.<sup><xref rid="CIT0135">135</xref></sup> Various enteric bacteria are also able to synthesize and release nitric oxide,<sup><xref rid="CIT0136">136</xref></sup> acetylcholine,<sup><xref rid="CIT0137">137</xref></sup> noradrenaline,<sup><xref rid="CIT0138">138</xref></sup> and dopamine.<sup><xref rid="CIT0139">139</xref></sup> The emerging field of “psychobiotics”<sup><xref rid="CIT0140">140</xref>,<xref rid="CIT0141">141</xref></sup> proposes to manipulate these neurotransmitter-producing bacteria to regulate gut and brain function.</p>
<p>In the third route, metabolite-activated immune cells may travel via the bloodstream to release soluble factors at the BBB which impacts its integrity and alters the inflammatory status of brain cells. Systemic inflammation and elevated circulating TNF promote extravasation of leukocytes and macrophages to the brain by upregulating adhesion molecules, chemokines, and matrix metalloproteases at the BBB and in the brain,<sup><xref rid="CIT0117">117</xref>,<xref rid="CIT0142">142</xref></sup> and by downregulating tight junctions. At steady state, during infection, and following brain injury, T cells from the gut can traffic to the brain.<sup><xref rid="CIT0143">143</xref>,<xref rid="CIT0144">144</xref></sup> Circulating immune cells may cross the BBB and choroid plexus to enter the brain and local draining lymph nodes<sup><xref rid="CIT0145">145</xref>,<xref rid="CIT0146">146</xref></sup> or infiltrate via meningeal vascular channels.<sup><xref rid="CIT0147">147</xref></sup> SCFA signaling may mitigate some of these effects, as altered lymphocyte migration from the gut in response to SCFAs can ameliorate uveitis<sup><xref rid="CIT0148">148</xref></sup> and modulation of the microbiota and its metabolites can impact neuroinflammation, and neurodegeneration.</p>
</sec>
<sec id="S0005-S2003">
<title>Microbiota-gut-brain pathways in neurodegenerative disease</title>
<p>Multiple neurological and neurodegenerative disease are now being associated with gut dysbiosis, following infection, inflammation or antibiotic use, although the mechanisms of gut-brain transmission of pathology have so far remained elusive. PD is of particular interest in this regard as a proposed etiology has developed from a growing collection of animal and epidemiological studies which link PD with pathogenic alpha synuclein (αSyn) protein production and accumulation in the gastrointestinal tract. A proposed sequence of events involves age- infection-, or dysbiosis-driven αSyn accumulation in the intestine, leading to trans-synaptic transmission of pathological forms of αSyn from enteric neurons to the vagus nerve, and retrograde axonal transport along the vagus to the brainstem.<sup><xref rid="CIT0149">149</xref>-<xref rid="CIT0151">151</xref></sup> This model draws on autopsy studies of Lewy bodies, and observations that onset of gastrointestinal symptoms in PD patients, and detection of pathological α-synuclein (αSyn) in gastrointestinal tissues in animal models of PD, are seen prior to the onset of motor symptoms. Also, rodent studies in which αSyn expression was chemically induced in enteric neurons, or in which recombinant αSyn was delivered to the gastric and/or duodenal wall, report subsequent αSyn detection in the vagal nerve and multiple brain regions.<sup><xref rid="CIT0152">152</xref>-<xref rid="CIT0155">155</xref></sup> The identification of αSyn also within intestinal enteroendocrine cells<sup><xref rid="CIT0156">156</xref></sup> is interesting in light of the recently described synaptic connections between subsets of these cells and vagal afferents,<sup><xref rid="CIT0113">113</xref></sup> providing a gut lumen-to brain communication pathway.</p>
<p>What events may trigger the initial generation of pathogenic αSyn in the gut, and whether αSyn propagation from the intestine to the vagus and/or brainstem occurs in humans and is causative in human PD pathology remain unknown. While transmission of αSyn via the vagal route has received the most attention, gut-brain transmission by other neural pathways (e.g. the splanchnic nerve innervating the colon, olfactory neurons<sup><xref rid="CIT0157">157</xref></sup>) or by trafficking immune cells is also possible. Moreover, vagal transmission is not absolutely required for PD development, as vagotomy delays but does not prevent PD-like pathology in mice<sup><xref rid="CIT0153">153</xref></sup> and while some human epidemiological studies suggest vagotomy is associated with lower risk of developing PD,<sup><xref rid="CIT0158">158</xref></sup> others do not.<sup><xref rid="CIT0159">159</xref>,<xref rid="CIT0160">160</xref></sup> The human appendix, which houses a diverse microbiome,<sup><xref rid="CIT0161">161</xref></sup> and in which pathology-associated αSyn can be also detected, has also been suggested as a site of gastrointestinal αSyn seeding.<sup><xref rid="CIT0162">162</xref></sup> While the history of appendectomy was associated with delayed onset of PD symptoms in a small late-onset cohort<sup><xref rid="CIT0163">163</xref></sup> a larger study found no effect,<sup><xref rid="CIT0164">164</xref></sup> and others find either no effect or a slightly increased risk of developing PD 5–10 years post-appendectomy.<sup><xref rid="CIT0165">165</xref>,<xref rid="CIT0166">166</xref></sup> As a reservoir of microbes and immune cells, the appendix could still have a role in modulating PD risk by influencing microbial and immune homeostasis. Given the interaction between gut microbes, enteroendocrine cells, enteric neurons and the enteric immune system discussed above, and recent evidence that bacterial proteins can enhance αSyn aggregation in animal models,<sup><xref rid="CIT0167">167</xref></sup> the activities of specific gut microbes or a more general ‘microbial dysbiosis’ could conceivably play a role in the transition from benign to pathogenic αSyn states.</p>
<p>In summary, a complex interplay of signalling between epithelial, immune, and neural cell signalling networks is involved in translating microbial metabolite changes in the gut and the brain, and may be involved in the etiology of neurodegenerative disease. Progress is being made in trying to dissect these interactions, but a better understanding of microbe-brain communication now requires cross-disciplinary multi-organ-based investigations.</p>
</sec>
</sec>
<sec id="S0006">
<title>Modulation of the gut microbiota as a potential therapeutic tool for promotion and restoration of brain health</title>
<p>Disruption of the complex ecosystem of the intestinal microbiota is now implicated in multiple conditions and diseases of both the intestine and the brain, and some of the routes by which microbes may act on the gut-brain axis are beginning to be unravelled. Manipulating or shaping the microbiota is therefore attracting attention as a viable strategy to prevent or treat various extra-intestinal diseases. The beneficial effects of an ‘optimized’ gut microbiota would include immune and epithelial homeostasis, enteric nervous system regulation, and optimal digestion and metabolism. This would theoretically protect against neurodegenerative disease by preventing metabolic, cardiovascular and inflammatory conditions which are associated with neurodegeneration but, as discussed above, could also protect BBB integrity and brain function by more direct means. Current therapeutic approaches under consideration include modifying the existing microbial composition in the gut by: altering nutrient availability to promote the growth of particular classes or species of bacteria (prebiotics); introducing or expanding ‘beneficial’ species (probiotics); or by wholesale transplant of entire communities or portions of communities from other intestinal donors (faecal microbial transplantation and more selective stool transplants). Below we consider how some of these approaches are beginning to be tested, and the potential for their use in improving blood-brain-barrier homeostasis and brain health.</p>
<sec id="S0006-S2001">
<title>Promoting growth of beneficial microbes via prebiotics</title>
<p>Prebiotics are non-digestible short-chain carbohydrates that, when ingested selectively, stimulate the development of some health-promoting colonic bacteria.<sup><xref rid="CIT0168">168</xref></sup> The nutritional properties exhibited by prebiotics derive from their resistance to hydrolysis in the upper gastrointestinal tract and their fermentation in the large intestine by mainly anaerobic bacteria.<sup><xref rid="CIT0169">169</xref></sup> Common prebiotics include disaccharides (lactulose), oligosaccharides (fructooligosaccharides, FOS, galactooligosaccharides, GOS) and polysaccharides (inulin).<sup><xref rid="CIT0170">170</xref></sup> Other compounds that can also be considered as prebiotics are resistant starches, pectin, whole grains, and polyphenols.<sup><xref rid="CIT0171">171</xref></sup> Once in the gut, prebiotic compounds are metabolized by the host microbiota and resulting metabolites, such as SCFAs, act on the brain through different pathways contributing to an effect on BBB permeability and neurological health (described above). Several animal studies have analyzed the effect of prebiotics on brain function<sup><xref rid="CIT0172">172</xref>-<xref rid="CIT0176">176</xref></sup> including modulating mood and stress responses by activating or supressing the hypothalamic-pituitary-adrenal (HPA) or “stress” axis. Serum and salivary cortisol are reliable indicators of HPA-activation (stress) and can be modulated by pre- and/or probiotics. The raised levels of circulating cortisol in germfree rodents<sup><xref rid="CIT0177">177</xref></sup> are reduced following the administration of probiotics.<sup><xref rid="CIT0178">178</xref></sup> In healthy mice, supplementation with long-chain FOS or short-chain GOS, which promote the growth of beneficial species such as Bifidobacteria,<sup><xref rid="CIT0172">172</xref></sup> decreased anxiety-related behaviors and increased social behavior.<sup><xref rid="CIT0179">179</xref></sup> Few studies investigating the benefit of prebiotics on human brain function have been published to date, and are so far inconclusive. One example in healthy adult volunteers described reduced stress response (salivary cortisol awakening response) after GOS intake.<sup><xref rid="CIT0180">180</xref></sup> In preterm infants, supplementation with different prebiotics showed improvement in brain development when compared to a control group.<sup><xref rid="CIT0181">181</xref></sup> Synergistic combinations of prebiotics and probiotics (synbiotics) have been found to improve age-related memory impairment in rats<sup><xref rid="CIT0182">182</xref></sup> and are now being trialled in human clinical studies to promote intestinal health.<sup><xref rid="CIT0183">183</xref>,<xref rid="CIT0184">184</xref></sup> One simple goal arising from such studies is devising optimized healthy diets which include all the required nutrients and prebiotics needed to decrease the number of harmful gut microbiota, and to increase the concentration of microorganisms producing metabolites which have beneficial effects on immunologic, metabolic and brain function to maximize health.</p>
</sec>
<sec id="S0006-S2002">
<title>Changing the gut microbiota composition via probiotics</title>
<p>Probiotics are non-pathogenic living microorganisms added to, or naturally occurring in, food products, that confer a health benefit to the host when administered in adequate amounts.<sup><xref rid="CIT0185">185</xref></sup> Examples include gut include species of the genera <italic>Lactobacillus, Bifidobacterium, Lactococcus, Streptococcus</italic>, and <italic>Enterococcus</italic>.<sup><xref rid="CIT0186">186</xref></sup> There is increasing interest in exploring the beneficial features of next-generation probiotics or live therapeutic products which include species not traditionally considered as probiotics, such as <italic>Akkermansia muciniphila</italic>,<sup><xref rid="CIT0187">187</xref></sup>
<italic>Faecalibacterium prausnitzii</italic>,<sup><xref rid="CIT0188">188</xref></sup> species of the genus <italic>Bacteroides</italic>,<sup><xref rid="CIT0189">189</xref></sup> and genetically modified <italic>Lactococcus</italic> strains carrying beneficial traits.<sup><xref rid="CIT0190">190</xref></sup> Recent evidence suggests that probiotic bacterial viability is not necessary to develop health-promoting effects in the host.<sup><xref rid="CIT0191">191</xref></sup> The administration of inactivated probiotic microorganisms, known as paraprobiotics, has been shown to confer benefits to the host without the risk of enhanced inflammatory responses in immunocompromised individuals.<sup><xref rid="CIT0192">192</xref>,<xref rid="CIT0193">193</xref></sup> In line with this concept, the term postbiotics, also known as metabiotics or simply metabolites, emerged to refer to bioactive soluble factors secreted by live bacteria or released after bacterial lysis, reinforcing the idea that cell viability is not essential to induce healthy effects.<sup><xref rid="CIT0191">191</xref></sup></p>
<p>Probiotic treatments have been associated with modulating mood and anxiety in animal models and humans. The first reported trial of using probiotic bacteria to treat mental health conditions was published in the early 20<sup>th</sup> century and described the use of lactic acid bacteria to successfully treat melancholia and constipation.<sup><xref rid="CIT0194">194</xref></sup> The term “psychobiotics” has since been coined to describe bacteria which, when ingested in adequate amounts, have a positive mental health effect.<sup><xref rid="CIT0140">140</xref></sup> Several human interventions provided evidence that psychobiotics can alter mental state. The intake of <italic>Lactobacillus helveticus</italic> and <italic>Bifidobacterium longum</italic> reduced 24-hour urinary free cortisol, a biomarker for stress response, in healthy volunteers.<sup><xref rid="CIT0195">195</xref></sup> Healthy students consuming fermented milk containing <italic>Lactobacillus casei</italic> strain Shirota had lower plasma cortisol compared to placebo group on the day before an examination,<xref rid="CIT0196"><sup>196</sup></xref> and a probiotic strain of <italic>Lactobacillus rhamnosus</italic> exhibited a protective effect on symptoms of postpartum depression.<sup><xref rid="CIT0197">197</xref></sup> One possible mechanism for the mood-altering effects of psychobiotics is by enhancing production of neurotransmitters, such as GABA and glutamate which control neural excitation-inhibition balance, and BDNF which is implicated in learning processes and control of fear.<sup><xref rid="CIT0198">198</xref></sup> Another possible mechanism is by altering the balance of circulating pro-and anti-inflammatory cytokines, restoring inflammation-induced BBB permeability, preventing potentially harmful material from entering the brain,<sup><xref rid="CIT0199">199</xref></sup> and promoting mental health and psychological resilience.<sup><xref rid="CIT0140">140</xref></sup></p>
<p>Probiotic modulation has also shown promise in alleviating symptoms of PD. Delivery of some probiotic cultures has shown beneficial effects on gastrointestinal symptoms in PD patients,<sup><xref rid="CIT0200">200</xref>,<xref rid="CIT0201">201</xref></sup> while one study delivering a <italic>Bifidobacteria/Lactobacilli</italic> mix found improvements in motor scores.<sup><xref rid="CIT0202">202</xref></sup> Probiotics may also prove useful in treating AD. Delivery of <italic>Bifidobacteria/Lactobacilli</italic> mixtures has shown several benefits in mouse and rat models of AD, including improvements in memory and learning tests, reduced measures of oxidative stress, reduction in histopathological markers in the brain,<sup><xref rid="CIT0203">203</xref>,<xref rid="CIT0204">204</xref></sup>and restoration of neuronal cell proteolytic functions.<sup><xref rid="CIT0205">205</xref></sup> Some small-scale exploratory human studies comparing AD patients before and after probiotic supplementation, again using <italic>Bifidobacteria/Lactobacilli</italic> mixtures, report improved mini-mental state examination (MMSE) scores and improvement in some metabolic and inflammatory markers.<sup><xref rid="CIT0206">206</xref>,<xref rid="CIT0207">207</xref></sup> Two recent randomized, double-blinded, placebo-controlled clinical trials show improved MMSE cores, reduced serum C-reactive protein (an inflammatory marker) and improved insulin metabolism in patients receiving probiotic mixture containing <italic>Bifidobacteria</italic> and <italic>Lactobacilli</italic> species.<sup><xref rid="CIT0208">208</xref>,<xref rid="CIT0209">209</xref></sup> As with PD, the mechanisms of probiotic-promoted neuroprotective effects in AD studies remain to be determined but may reflect positive effects on gut barrier health leading to improved immune and metabolic health (e.g. protection against type-II diabetes, decreased systemic inflammation), which in turn protects against BBB breakdown and neural pathology.</p>
</sec>
<sec id="S0006-S2003">
<title>Changing the gut microbiota via fecal microbiota transplantation (FMT)</title>
<p>FMT is the therapeutic administration of fecal material containing gut microbiota from a healthy donor to a recipient with a dysbiosis-related condition, via enema, nasogastric, nasoenteric or endoscopic routes, to restore normal diversity and function in the microbial community.<sup><xref rid="CIT0210">210</xref></sup> FMT was first described in a medical manual for emergencies written by the Chinese alchemist Ge Hong in the fourth century, who reported that people suffering from food poisoning and diarrhea recovered after oral administration of fecal suspensions (‘yellow dragon soup’).<sup><xref rid="CIT0211">211</xref></sup> A more recent and well-documented use of FMT is the treatment of patients with <italic>Clostridium difficile</italic> infection, with efficacy rates of approximately 90%.<sup><xref rid="CIT0212">212</xref></sup> FMT has also been used to treat ulcerative colitis but with an effectiveness of lower than 25%.<sup><xref rid="CIT0213">213</xref></sup> The overall results of several randomized controlled trials using FMT to treat irritable bowel syndrome are so far inconclusive regarding efficacy in improving severity scores.<sup><xref rid="CIT0214">214</xref></sup> Due to the bidirectional signalling interactions along the microbiota-gut-brain axis, FMT has also been suggested as a potential treatment for extra-intestinal disorders, including neurological conditions. Bercik and colleagues<sup><xref rid="CIT0215">215</xref></sup> published one of the first studies using FMT to modulate brain function and modulate host behavior in mice. They colonized germfree BALB/c mice, usually a timid strain, with microbiota from the more exploratory NIH Swiss strain. The BALB/c mice displayed less timid and more exploratory behaviour after FMT, associated with higher levels of BDNF in the brain. In the reverse experiment, colonization of germfree NIH Swiss mice with BALB/c microbiota reduced exploratory behavior, suggesting the gut microbiota play a key role in behavior.<sup><xref rid="CIT0215">215</xref></sup> In support of this study, Zheng and colleagues<sup><xref rid="CIT0216">216</xref></sup> showed that germfree mice transplanted with microbiota from major depressive disorder patients displayed depression-like behavior. Kelly and colleagues<sup><xref rid="CIT0217">217</xref></sup> also found physiological and behavioral features of depression in microbiota-depleted rats after transplantation with fecal microbiota from depressed patients, as well as a dysregulation in tryptophan metabolism, similar to that reported in autism, schizophrenia and neurodegenerative diseases.<sup><xref rid="CIT0218">218</xref>,<xref rid="CIT0219">219</xref></sup> In a disease model, FMT from normal mice has neuroprotective effects in a mouse model of PD, including reducing TNF-driven neuroinflammation and increasing brain levels of dopamine and serotonin, leading to improvement in motor symptoms.<sup><xref rid="CIT0220">220</xref></sup> Currently, studies focusing on the effect of FMT on the neurodegenerative disease in humans are lacking. Anecdotally, neurologic improvement in one patient with PD has been reported following FMT for chronic constipation.<sup><xref rid="CIT0221">221</xref></sup> Given the possible gut-brain propagation of pathogenic αSyn discussed above, the use of FMT to modulate the intestinal production of αSyn could be protective against PD by providing a ‘protective’ microbiota, which either does not promote aberrant protein folding or outcompetes pathogenic strains, or by maintaining immune, neural and epithelial barrier homeostasis such that any aberrant protein folding in the gut lumen is contained locally. However, safety remains a major concern in translating FMT research to humans. Stool donors and samples for FMT are currently tested for different potentially pathogenic bacteria, viruses, parasites, and other microorganisms,<sup><xref rid="CIT0222">222</xref></sup> but this is far from knowing the complete microbial composition of the sample to be transplanted, raising both safety concerns and issues over how to interpret results. The delivery of selective microbial mixtures, as in stool substitute transplant therapy (SSTT) or microbial ecosystem therapeutics (MET), in which purified beneficial intestinal bacterial cultures derived from a single healthy human donor are delivered into a patient’s gastrointestinal tract, could minimize the potential risk of pathogenicity, not only due to infection but also to metabolic disease development or oncogenic potential. By inducing large-scale shifts in the intestinal microbiota by methods such as FMT and SSTT, metabolite production in the gut and subsequent availability in circulation may also be significantly altered. One recent study of African turquoise killifish (<italic>Nothobranchius furzeri</italic>) using metabolomic analysis of intestine, brain, liver, heart, skeletal muscle, serum, and stool, found important metabolic pathways are modified during killifish aging and that these changes could in part be reversed by gut microbiota transfers from young donors.<sup><xref rid="CIT0223">223</xref></sup> New work on metabolomics will be vital to understanding the complex metabolic interactions between host and microbes and how metabolic profiles are associated with health and disease. By harnessing such methods, and combining this information with microbial ‘omics and systems biology approaches, it may be possible to identify beneficial vs detrimental microbial and metabolic profiles and pathways for gut and brain health, and to work towards optimized personal therapies to achieve beneficial conditions using a combination of microbial and dietary intervention. These and other improvements in our understanding of microbe–host interactions at the gut and brain barriers will hopefully accelerate research in the use of microbiota-modulating therapies to prevent and treat neurological and neurodegenerative disease.</p>
</sec>
</sec>
<sec id="S0007">
<title>Conclusions</title>
<p>Gut microbiome research is rapidly expanding, with recent advances in high-throughput ‘omics technologies, providing us with a better understanding of the composition and functionality of such a complex ecosystem. Further investigation of bacterial metabolites and their effects on hormone production, immune signalling, and neural function will enable a fuller understanding of brain responses to age- and disease-associated alterations in the microbiota. Despite our current limited knowledge of specific mechanisms, dietary and microbial modulation are showing promise as potential strategies to tackle some neurodegenerative and neurological diseases. A deeper understanding of gut microbial ecology, metabolism, and signalling networks within the host may lead to a new generation of microbiome-targeted strategies, both for disease treatment and prevention.</p>
</sec>
</body>
<back>
<sec id="S0008">
<title>Disclosure of interest</title>
<p>The authors report no conflict of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="CIT0001">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duda-Chodak</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tarko</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Satora</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sroka</surname><given-names>P.</given-names></name></person-group>
<article-title>Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review</article-title>. <source/>Eur J Nutr. <year>2015</year>;<volume>54</volume>:<fpage>325</fpage>–<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00394-015-0852-y</pub-id>.<pub-id pub-id-type="pmid">25672526</pub-id></mixed-citation>
</ref>
<ref id="CIT0002">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sender</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Milo</surname><given-names>R</given-names></name></person-group>
<article-title>Revised estimates for the number of human and bacteria cells in the body</article-title>. <source/>PLoS Biol. <year>2016</year>;<volume>14</volume>:<fpage>e1002533</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.1002533</pub-id>.<pub-id pub-id-type="pmid">27541692</pub-id></mixed-citation>
</ref>
<ref id="CIT0003">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laval</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Natividad</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Chain</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Miquel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Desclee de Maredsous</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Capronnier</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sokol</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Verdu</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>van Hylckama Vlieg</surname><given-names>JET</given-names></name>, et al</person-group>
<article-title><italic>Lactobacillus rhamnosus</italic> CNCM I-3690 and the commensal bacterium <italic>Faecalibacterium prausnitzii</italic> A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice</article-title>. <source/>Gut Microbes. <year>2015</year>;<volume>6</volume>:<fpage>1</fpage>–<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.4161/19490976.2014.990784</pub-id>.<pub-id pub-id-type="pmid">25517879</pub-id></mixed-citation>
</ref>
<ref id="CIT0004">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nash</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Ranadheera</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Georgousopoulou</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Mellor</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Panagiotakos</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>McKune</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kellett</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Naumovski</surname><given-names>N</given-names></name></person-group>
<article-title>The effects of grape and red wine polyphenols on gut microbiota – a systematic review</article-title>. <source/>Food Res Int (Ottawa, Ont). <year>2018</year>;<volume>113</volume>:<fpage>277</fpage>–<lpage>287</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.foodres.2018.07.019</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0005">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fung</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Hsiao</surname><given-names>EY</given-names></name></person-group>
<article-title>Interactions between the microbiota, immune and nervous systems in health and disease</article-title>. <source/>Nat Neurosci. <year>2017</year>;<volume>20</volume>:<fpage>145</fpage>–<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.4476</pub-id>.<pub-id pub-id-type="pmid">28092661</pub-id></mixed-citation>
</ref>
<ref id="CIT0006">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braniste</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Al-Asmakh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kowal</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Anuar</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Abbaspour</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Toth</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Korecka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bakocevic</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Kundu</surname><given-names>P</given-names></name>, et al</person-group>
<article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>. <source/>Sci Transl Med. <year>2014</year>;<volume>6</volume>:<fpage>263ra158</fpage>.</mixed-citation>
</ref>
<ref id="CIT0007">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fröhlich</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Farzi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mayerhofer</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Reichmann</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Jacan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zinser</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bordag</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Magnes</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fröhlich</surname><given-names>E</given-names></name>, et al</person-group>
<article-title>Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication</article-title>. <source/>Brain Behav Immun. <year>2016</year>;<volume>56</volume>:<fpage>140</fpage>–<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2016.02.020</pub-id>.<pub-id pub-id-type="pmid">26923630</pub-id></mixed-citation>
</ref>
<ref id="CIT0008">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spielman</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Klegeris</surname><given-names>A</given-names></name></person-group>
<article-title>The role of insulin and incretins in neuroinflammation and neurodegeneration</article-title>. <source/>Immunoendocrinology. <year>2014</year>;<volume>1:e391. doi:10.14800/immunoendocrinology.391.</volume></mixed-citation>
</ref>
<ref id="CIT0009">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Block</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>JS</given-names></name></person-group>
<article-title>Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism</article-title>. <source/>Prog Neurobiol. <year>2005</year>;<volume>76</volume>:<fpage>77</fpage>–<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pneurobio.2005.06.004</pub-id>.<pub-id pub-id-type="pmid">16081203</pub-id></mixed-citation>
</ref>
<ref id="CIT0010">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Block</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Zecca</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>JS</given-names></name></person-group>
<article-title>Microglia-mediated neurotoxicity: uncovering the molecular mechanisms</article-title>. <source/>Nat Rev Neurosci. <year>2007</year>;<volume>8</volume>:<fpage>57</fpage>–<lpage>69</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn2038</pub-id>.<pub-id pub-id-type="pmid">17180163</pub-id></mixed-citation>
</ref>
<ref id="CIT0011">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campos-Bedolla</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Walter</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Veszelka</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Deli</surname><given-names>MA</given-names></name></person-group>
<article-title>Role of the blood-brain barrier in the nutrition of the central nervous system</article-title>. <source/>Arch Med Res. <year>2014</year>;<volume>45</volume>:<fpage>610</fpage>–<lpage>638</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arcmed.2014.11.018</pub-id>.<pub-id pub-id-type="pmid">25481827</pub-id></mixed-citation>
</ref>
<ref id="CIT0012">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harach</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Marungruang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dutilleul</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Cheatham</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mc Coy</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Neher</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jucker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fåk</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bolmont</surname><given-names>T.</given-names></name></person-group>
<article-title>Reduction of Alzheimer’s disease beta-amyloid pathology in the absence of gut microbiota</article-title>. <source/>arXiv:1509.02273v2. <year>2015</year>.</mixed-citation>
</ref>
<ref id="CIT0013">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minter</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Leone</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Ringus</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Oyler-Castrillo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Musch</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Holtzman</surname><given-names>DM</given-names></name>, et al</person-group>
<article-title>Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease</article-title>. <source/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>30028</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep30028</pub-id>.<pub-id pub-id-type="pmid">27443609</pub-id></mixed-citation>
</ref>
<ref id="CIT0014">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheperjans</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Aho</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Koskinen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Paulin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pekkonen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Haapaniemi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kaakkola</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Eerola-Rautio</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pohja</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Gut microbiota are related to Parkinson’s disease and clinical phenotype</article-title>. <source/>Mov Disord. <year>2015</year>;<volume>30</volume>:<fpage>350</fpage>–<lpage>358</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.26069</pub-id>.<pub-id pub-id-type="pmid">25476529</pub-id></mixed-citation>
</ref>
<ref id="CIT0015">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sampson</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Debelius</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Thron</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shastri</surname><given-names>GG</given-names></name>, <name name-style="western"><surname>Ilhan</surname><given-names>ZE</given-names></name>, <name name-style="western"><surname>Challis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schretter</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Rocha</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gradinaru</surname><given-names>V</given-names></name>, et al</person-group>
<article-title>Gut microbiota regulate motor deficits and Neuroinflammation in a model of Parkinson’s disease</article-title>. <source/>Cell. <year>2016</year>;<volume>167</volume>:<fpage>1469</fpage>–<lpage>80 e12</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2016.11.018</pub-id>.<pub-id pub-id-type="pmid">27912057</pub-id></mixed-citation>
</ref>
<ref id="CIT0016">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stern</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gautier</surname><given-names>R</given-names></name></person-group>
<article-title>Recherches Sur Le Liquide Céphalo-Rachidien: I.–les Rapports Entre Le Liquide Céphalo-Rachidien et la Circulation Sanguine</article-title>. <source/>Arch Int Physiol. <year>1921</year>;<volume>17</volume>:<fpage>138</fpage>–<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.3109/13813452109146211</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0017">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brightman</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Reese</surname><given-names>TS</given-names></name></person-group>
<article-title>Junctions between intimately apposed cell membranes in the vertebrate brain</article-title>. <source/>J Cell Biol. <year>1969</year>;<volume>40</volume>:<fpage>648</fpage>–<lpage>677</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.40.3.648</pub-id>.<pub-id pub-id-type="pmid">5765759</pub-id></mixed-citation>
</ref>
<ref id="CIT0018">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reese</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Karnovsky</surname><given-names>MJ</given-names></name></person-group>
<article-title>Fine structural localization of a blood-brain barrier to exogenous peroxidase</article-title>. <source/>J Cell Biol. <year>1967</year>;<volume>34</volume>:<fpage>207</fpage>–<lpage>217</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.34.1.207</pub-id>.<pub-id pub-id-type="pmid">6033532</pub-id></mixed-citation>
</ref>
<ref id="CIT0019">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruck</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bittner</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Meuth</surname><given-names>SG</given-names></name></person-group>
<article-title>Blood-brain barrier modeling: challenges and perspectives</article-title>. <source/>Neural Regen Res. <year>2015</year>;<volume>10</volume>:<fpage>889</fpage>–<lpage>891</lpage>. doi:<pub-id pub-id-type="doi">10.4103/1673-5374.158342</pub-id>.<pub-id pub-id-type="pmid">26199600</pub-id></mixed-citation>
</ref>
<ref id="CIT0020">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hawkins</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>TP</given-names></name></person-group>
<article-title>The blood-brain barrier/neurovascular unit in health and disease</article-title>. <source/>Pharmacol Rev. <year>2005</year>;<volume>57</volume>:<fpage>173</fpage>–<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1124/pr.57.2.4</pub-id>.<pub-id pub-id-type="pmid">15914466</pub-id></mixed-citation>
</ref>
<ref id="CIT0021">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballabh</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nedergaard</surname><given-names>M</given-names></name></person-group>
<article-title>The blood-brain barrier: an overview: structure, regulation, and clinical implications</article-title>. <source/>Neurobiol Dis. <year>2004</year>;<volume>16</volume>:<fpage>1</fpage>–<lpage>13</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nbd.2003.12.016</pub-id>.<pub-id pub-id-type="pmid">15207256</pub-id></mixed-citation>
</ref>
<ref id="CIT0022">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vorbrodt</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Dobrogowska</surname><given-names>DH</given-names></name></person-group>
<article-title>Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist’s view</article-title>. <source/>Brain Res Brain Res Rev. <year>2003</year>;<volume>42</volume>:<fpage>221</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">12791441</pub-id></mixed-citation>
</ref>
<ref id="CIT0023">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rustenhoven</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jansson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Smyth</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Dragunow</surname><given-names>M</given-names></name></person-group>
<article-title>Brain pericytes as mediators of neuroinflammation</article-title>. <source/>Trends Pharmacol Sci. <year>2017</year>;<volume>38</volume>:<fpage>291</fpage>–<lpage>304</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tips.2016.12.001</pub-id>.<pub-id pub-id-type="pmid">28017362</pub-id></mixed-citation>
</ref>
<ref id="CIT0024">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moura</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sarmento</surname><given-names>B</given-names></name></person-group>
<article-title>The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier</article-title>. <source/>Prog Neurobiol. <year>2017</year>;<volume>159</volume>:<fpage>39</fpage>–<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pneurobio.2017.09.001</pub-id>.<pub-id pub-id-type="pmid">28899762</pub-id></mixed-citation>
</ref>
<ref id="CIT0025">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Ronnback</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hansson</surname><given-names>E</given-names></name></person-group>
<article-title>Astrocyte-endothelial interactions at the blood-brain barrier</article-title>. <source/>Nat Rev Neurosci. <year>2006</year>;<volume>7</volume>:<fpage>41</fpage>–<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn1824</pub-id>.<pub-id pub-id-type="pmid">16371949</pub-id></mixed-citation>
</ref>
<ref id="CIT0026">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liebner</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dijkhuizen</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Reiss</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Plate</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Agalliu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Constantin</surname><given-names>G</given-names></name></person-group>
<article-title>Functional morphology of the blood-brain barrier in health and disease</article-title>. <source/>Acta Neuropathol. <year>2018</year>;<volume>135</volume>:<fpage>311</fpage>–<lpage>336</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00401-018-1815-1</pub-id>.<pub-id pub-id-type="pmid">29411111</pub-id></mixed-citation>
</ref>
<ref id="CIT0027">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ke</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>YP</given-names></name></person-group>
<article-title>Th17 cell-mediated neuroinflammation is involved in neurodegeneration of abeta1-42-induced Alzheimer’s disease model rats</article-title>. <source/>PLoS One. <year>2013</year>;<volume>8</volume>:<fpage>e75786</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0075786</pub-id>.<pub-id pub-id-type="pmid">24124514</pub-id></mixed-citation>
</ref>
<ref id="CIT0028">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sommer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maxreiter</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Krach</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Fadler</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Grosch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Maroni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Graef</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Eberhardt</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Riemenschneider</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Yeo</surname><given-names>GW</given-names></name>, et al</person-group>
<article-title>Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson’s disease</article-title>. <source/>Cell Stem Cell. <year>2018</year>;<volume>23</volume>:<fpage>123</fpage>–<lpage>31 e6</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.stem.2018.06.015</pub-id>.<pub-id pub-id-type="pmid">29979986</pub-id></mixed-citation>
</ref>
<ref id="CIT0029">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sagare</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Winkler</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Ramanathan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zlokovic</surname><given-names>BV</given-names></name></person-group>
<article-title>Pericyte loss influences Alzheimer-like neurodegeneration in mice</article-title>. <source/>Nat Commun. <year>2013</year>;<volume>4</volume>:<fpage>2932</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms3932</pub-id>.<pub-id pub-id-type="pmid">24336108</pub-id></mixed-citation>
</ref>
<ref id="CIT0030">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group>
<article-title><italic>Clostridium butyricum</italic> exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut-brain axis</article-title>. <source/>Neurogastroenterol Motil. <year>2018</year>;<volume>30</volume>:<fpage>e13260</fpage>. doi:<pub-id pub-id-type="doi">10.1111/nmo.2018.30.issue-5</pub-id>.<pub-id pub-id-type="pmid">29193450</pub-id></mixed-citation>
</ref>
<ref id="CIT0031">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Z-Q</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group>
<article-title>Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice</article-title>. <source/>Brain Res. <year>2016</year>;<volume>1642</volume>:<fpage>70</fpage>–<lpage>78</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.brainres.2016.03.031</pub-id>.<pub-id pub-id-type="pmid">27017959</pub-id></mixed-citation>
</ref>
<ref id="CIT0032">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McMillin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Galindo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Frampton</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pae</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>DeMorrow</surname><given-names>S</given-names></name></person-group>
<article-title>Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms</article-title>. <source/>Dig Liver Dis. <year>2014</year>;<volume>46</volume>:<fpage>527</fpage>–<lpage>534</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.dld.2014.01.159</pub-id>.<pub-id pub-id-type="pmid">24629820</pub-id></mixed-citation>
</ref>
<ref id="CIT0033">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoyles</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Snelling</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Umlai</surname><given-names>UK</given-names></name>, <name name-style="western"><surname>Nicholson</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Carding</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Glen</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>McArthur</surname><given-names>S</given-names></name></person-group>
<article-title>Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier</article-title>. <source/>Microbiome. <year>2018</year>;<volume>6</volume>:<fpage>55</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40168-018-0432-5</pub-id>.<pub-id pub-id-type="pmid">29562936</pub-id></mixed-citation>
</ref>
<ref id="CIT0034">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganapathy</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Thangaraju</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Prasad</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>N</given-names></name></person-group>
<article-title>Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host</article-title>. <source/>Curr Opin Pharmacol. <year>2013</year>;<volume>13</volume>:<fpage>869</fpage>–<lpage>874</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coph.2013.08.006</pub-id>.<pub-id pub-id-type="pmid">23978504</pub-id></mixed-citation>
</ref>
<ref id="CIT0035">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reichardt</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Belenguer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>McWilliam Leitch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Flint</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Louis</surname><given-names>P</given-names></name></person-group>
<article-title>Phylogenetic distribution of three pathways for propionate production within the human gut microbiota</article-title>. <source/>Isme J. <year>2014</year>;<volume>8</volume>:<fpage>1323</fpage>–<lpage>1335</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ismej.2014.14</pub-id>.<pub-id pub-id-type="pmid">24553467</pub-id></mixed-citation>
</ref>
<ref id="CIT0036">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salminen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bouley</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Boutron-Ruault</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Cummings</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Franck</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Isolauri</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Moreau</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Roberfroid</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rowland</surname><given-names>I</given-names></name></person-group>
<article-title>Functional food science and gastrointestinal physiology and function</article-title>. <source/>Br J Nutr. <year>1998</year>;<volume>80</volume>:<fpage>S147</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">9849357</pub-id></mixed-citation>
</ref>
<ref id="CIT0037">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macfabe</surname><given-names>DF</given-names></name></person-group>
<article-title>Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders</article-title>. <source/>Microb Ecol Health Dis. <year>2012</year>;<volume>23:19260. doi:10.3402/mehd.v23i0.19260</volume>.</mixed-citation>
</ref>
<ref id="CIT0038">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Rowe</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Chuang</surname><given-names>DM</given-names></name></person-group>
<article-title>Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action</article-title>. <source/>J Pharmacol Exp Ther. <year>2007</year>;<volume>321</volume>:<fpage>892</fpage>–<lpage>901</lpage>. doi:<pub-id pub-id-type="doi">10.1124/jpet.107.120188</pub-id>.<pub-id pub-id-type="pmid">17371805</pub-id></mixed-citation>
</ref>
<ref id="CIT0039">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matt</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Lawson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Mailing</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Woods</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>RW</given-names></name></person-group>
<article-title>Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice</article-title>. <source/>Front Immunol. <year>2018</year>;<volume>9</volume>:<fpage>1832</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2018.01832</pub-id>.<pub-id pub-id-type="pmid">30154787</pub-id></mixed-citation>
</ref>
<ref id="CIT0040">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Radulovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schrick</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sananbenesi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Godovac-Zimmermann</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Radulovic</surname><given-names>J</given-names></name></person-group>
<article-title>Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior</article-title>. <source/>Neurobiol Learn Mem. <year>2007</year>;<volume>87</volume>:<fpage>149</fpage>–<lpage>158</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nlm.2006.08.003</pub-id>.<pub-id pub-id-type="pmid">16979915</pub-id></mixed-citation>
</ref>
<ref id="CIT0041">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MacFabe</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Cain</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Rodriguez-Capote</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Franklin</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Hoffman</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Boon</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Kavaliers</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ossenkopp</surname><given-names>K-P</given-names></name></person-group>
<article-title>Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders</article-title>. <source/>Behav Brain Res. <year>2007</year>;<volume>176</volume>:<fpage>149</fpage>–<lpage>169</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbr.2006.07.025</pub-id>.<pub-id pub-id-type="pmid">16950524</pub-id></mixed-citation>
</ref>
<ref id="CIT0042">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erny</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hrabe de Angelis</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Jaitin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wieghofer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Staszewski</surname><given-names>O</given-names></name>, <name name-style="western"><surname>David</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Keren-Shaul</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mahlakoiv</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Jakobshagen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Buch</surname><given-names>T</given-names></name>, et al</person-group>
<article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>. <source/>Nat Neurosci. <year>2015</year>;<volume>18</volume>:<fpage>965</fpage>–<lpage>977</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.4030</pub-id>.<pub-id pub-id-type="pmid">26030851</pub-id></mixed-citation>
</ref>
<ref id="CIT0043">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zilberter</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zilberter</surname><given-names>M</given-names></name></person-group>
<article-title>The vicious circle of hypometabolism in neurodegenerative diseases: ways and mechanisms of metabolic correction</article-title>. <source/>J Neurosci Res. <year>2017</year>;<volume>95</volume>:<fpage>2217</fpage>–<lpage>2235</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jnr.24064</pub-id>.<pub-id pub-id-type="pmid">28463438</pub-id></mixed-citation>
</ref>
<ref id="CIT0044">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emery</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Shoemark</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Batstone</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Waterfall</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Coghill</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Cerajewska</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>M</given-names></name>, <name name-style="western"><surname>West</surname><given-names>NX</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>SJ</given-names></name></person-group>
<article-title>16S rRNA next generation sequencing analysis shows bacteria in Alzheimer’s post-mortem brain</article-title>. <source/>Front Aging Neurosci. <year>2017</year>;<volume>9</volume>:<fpage>195</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2017.00077</pub-id>.<pub-id pub-id-type="pmid">28676754</pub-id></mixed-citation>
</ref>
<ref id="CIT0045">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Readhead</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Haure-Mirande</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Funk</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Richards</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Shannon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Haroutunian</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Sano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Beckmann</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>ND</given-names></name>, et al</person-group>
<article-title>Multiscale Analysis of independent Alzheimer’s Cohorts finds disruption of molecular, genetic, and clinical networks by human Herpesvirus</article-title>. <source/>Neuron. <year>2018</year>;<volume>99</volume>:<fpage>64</fpage>–<lpage>82 e7</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2018.05.023</pub-id>.<pub-id pub-id-type="pmid">29937276</pub-id></mixed-citation>
</ref>
<ref id="CIT0046">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pisa</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Alonso</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fernandez-Fernandez</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Rabano</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Carrasco</surname><given-names>L</given-names></name></person-group>
<article-title>Polymicrobial infections in brain tissue from Alzheimer’s disease patients</article-title>. <source/>Sci Rep. <year>2017</year>;<volume>7</volume>:<fpage>5559</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-017-05903-y</pub-id>.<pub-id pub-id-type="pmid">28717130</pub-id></mixed-citation>
</ref>
<ref id="CIT0047">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pisa</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Alonso</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rabano</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rodal</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Carrasco</surname><given-names>L</given-names></name></person-group>
<article-title>Different brain regions are infected with fungi in Alzheimer’s disease</article-title>. <source/>Sci Rep. <year>2015</year>;<volume>5</volume>:<fpage>15015</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep15015</pub-id>.<pub-id pub-id-type="pmid">26468932</pub-id></mixed-citation>
</ref>
<ref id="CIT0048">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pisa</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Alonso</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Juarranz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rabano</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Carrasco</surname><given-names>L</given-names></name></person-group>
<article-title>Direct visualization of fungal infection in brains from patients with Alzheimer’s disease</article-title>. <source/>J Alzheimers Dis. <year>2015</year>;<volume>43</volume>:<fpage>613</fpage>–<lpage>624</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-141386</pub-id>.<pub-id pub-id-type="pmid">25125470</pub-id></mixed-citation>
</ref>
<ref id="CIT0049">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bensasson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Dicks</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ludwig</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bond</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Elliston</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>IN</given-names></name>, <name name-style="western"><surname>James</surname><given-names>SA</given-names></name></person-group>
<article-title>Diverse Lineages of <italic>Candida albicans</italic> live on old Oaks</article-title>. <source/>Genetics. <year>2019</year>;<volume>211</volume>:<fpage>277</fpage>–<lpage>288</lpage>. doi:<pub-id pub-id-type="doi">10.1534/genetics.118.301482</pub-id>.<pub-id pub-id-type="pmid">30463870</pub-id></mixed-citation>
</ref>
<ref id="CIT0050">
<label>50.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lachance</surname><given-names>M-A</given-names></name>, <name name-style="western"><surname>Boekhout</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Scorzetti</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fell</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Kurtzman</surname><given-names>CP</given-names></name></person-group>
<chapter-title>Candida Berkhout (1923)</chapter-title> In: Kurtzman CP, Fell JW, Boekhout T, editors. <source/>The yeasts. <publisher-name>Elsevier</publisher-name>; <year>2011</year> p. <fpage>987</fpage>–<lpage>1278. doi:10.1016/B978-0-444-52149-1.00090-2</lpage>.</mixed-citation>
</ref>
<ref id="CIT0051">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bennett</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>de Aguiar Vallim</surname><given-names>TQ</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Shih</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Allayee</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Crooke</surname><given-names>R</given-names></name>, et al</person-group>
<article-title>Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation</article-title>. <source/>Cell Metab. <year>2013</year>;<volume>17</volume>:<fpage>49</fpage>–<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2012.12.011</pub-id>.<pub-id pub-id-type="pmid">23312283</pub-id></mixed-citation>
</ref>
<ref id="CIT0052">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romano</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Vivas</surname><given-names>EI</given-names></name>, <name name-style="western"><surname>Amador-Noguez</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rey</surname><given-names>FE</given-names></name></person-group>
<article-title>Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide</article-title>. <source/>MBio. <year>2015</year>;<volume>6</volume>:<fpage>e02481</fpage>. doi:<pub-id pub-id-type="doi">10.1128/mBio.02481-14</pub-id>.<pub-id pub-id-type="pmid">25784704</pub-id></mixed-citation>
</ref>
<ref id="CIT0053">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Del Rio</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zimetti</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Caffarra</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tassotti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bernini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Brighenti</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zanotti</surname><given-names>I</given-names></name></person-group>
<article-title>The gut microbial metabolite trimethylamine-N-oxide is present in human cerebrospinal fluid</article-title>. <source/>Nutrients. <year>2017</year>;<volume>9:1053</volume>.</mixed-citation>
</ref>
<ref id="CIT0054">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bae</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ulrich</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Neuhouser</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Malysheva</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Cushing-Haugen</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>T-YD</given-names></name>, et al</person-group>
<article-title>Plasma choline metabolites and colorectal cancer risk in the women’s health initiative observational study</article-title>. <source/>Cancer Res. <year>2014</year>;<volume>74</volume>:<fpage>7442</fpage>–<lpage>7452</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-1835</pub-id>.<pub-id pub-id-type="pmid">25336191</pub-id></mixed-citation>
</ref>
<ref id="CIT0055">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koeth</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Levison</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Buffa</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Org</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sheehy</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Britt</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, et al</person-group>
<article-title>Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis</article-title>. <source/>Nat Med. <year>2013</year>;<volume>19</volume>:<fpage>576</fpage>–<lpage>585</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.3145</pub-id>.<pub-id pub-id-type="pmid">23563705</pub-id></mixed-citation>
</ref>
<ref id="CIT0056">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brugere</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Borrel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gaci</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tottey</surname><given-names>W</given-names></name>, <name name-style="western"><surname>O’Toole</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Malpuech-Brugere</surname><given-names>C</given-names></name></person-group>
<article-title>Archaebiotics: proposed therapeutic use of Archaea to prevent trimethylaminuria and cardiovascular disease</article-title>. <source/>Gut Microbes. <year>2014</year>;<volume>5</volume>:<fpage>5</fpage>–<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.4161/gmic.26749</pub-id>.<pub-id pub-id-type="pmid">24247281</pub-id></mixed-citation>
</ref>
<ref id="CIT0057">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaci</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Borrel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Tottey</surname><given-names>W</given-names></name>, <name name-style="western"><surname>O’Toole</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Brugere</surname><given-names>JF</given-names></name></person-group>
<article-title>Archaea and the human gut: new beginning of an old story</article-title>. <source/>World J Gastroenterol. <year>2014</year>;<volume>20</volume>:<fpage>16062</fpage>–<lpage>16078</lpage>. doi:<pub-id pub-id-type="doi">10.3748/wjg.v20.i43.16062</pub-id>.<pub-id pub-id-type="pmid">25473158</pub-id></mixed-citation>
</ref>
<ref id="CIT0058">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nkamga</surname><given-names>VD</given-names></name>, <name name-style="western"><surname>Lotte</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Chirio</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lonjon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roger</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Drancourt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ruimy</surname><given-names>R</given-names></name></person-group>
<article-title>Methanobrevibacter oralis detected along with <italic>Aggregatibacter actinomycetemcomitans</italic> in a series of community-acquired brain abscesses</article-title>. <source/>Clin Microbiol Infect. <year>2018</year>;<volume>24</volume>:<fpage>207</fpage>–<lpage>208</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmi.2017.08.021</pub-id>.<pub-id pub-id-type="pmid">28882726</pub-id></mixed-citation>
</ref>
<ref id="CIT0059">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dumas</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Rothwell</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Hoyles</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Aranias</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chilloux</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Calderari</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Noll</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Péan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Boulangé</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Blancher</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>Microbial-Host Co-metabolites are prodromal markers predicting Phenotypic Heterogeneity in behavior, obesity, and impaired glucose tolerance</article-title>. <source/>Cell Rep. <year>2017</year>;<volume>20</volume>:<fpage>136</fpage>–<lpage>148</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2017.06.039</pub-id>.<pub-id pub-id-type="pmid">28683308</pub-id></mixed-citation>
</ref>
<ref id="CIT0060">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lupachyk</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Watcho</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Stavniichuk</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Shevalye</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Obrosova</surname><given-names>IG</given-names></name></person-group>
<article-title>Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy</article-title>. <source/>Diabetes. <year>2013</year>;<volume>62</volume>:<fpage>944</fpage>–<lpage>952</lpage>. doi:<pub-id pub-id-type="doi">10.2337/db12-0716</pub-id>.<pub-id pub-id-type="pmid">23364451</pub-id></mixed-citation>
</ref>
<ref id="CIT0061">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsumoto</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nagase</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hirose</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tokuyama</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yasui</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kadono</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ueki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kadowaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name></person-group>
<article-title>Regulation of bone resorption and sealing zone formation in osteoclasts occurs through protein kinase B-mediated microtubule stabilization</article-title>. <source/>J Bone Miner Res. <year>2013</year>;<volume>28</volume>:<fpage>1191</fpage>–<lpage>1202</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jbmr.1844</pub-id>.<pub-id pub-id-type="pmid">23239117</pub-id></mixed-citation>
</ref>
<ref id="CIT0062">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tseng</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Graves</surname><given-names>DJ</given-names></name></person-group>
<article-title>Natural methylamine osmolytes, trimethylamine N-oxide and betaine, increase tau-induced polymerization of microtubules</article-title>. <source/>Biochem Biophys Res Commun. <year>1998</year>;<volume>250</volume>:<fpage>726</fpage>–<lpage>730</lpage>. doi:<pub-id pub-id-type="doi">10.1006/bbrc.1998.9382</pub-id>.<pub-id pub-id-type="pmid">9784413</pub-id></mixed-citation>
</ref>
<ref id="CIT0063">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drewes</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ebneth</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Preuss</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Mandelkow</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Mandelkow</surname><given-names>E</given-names></name></person-group>
<article-title>MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption</article-title>. <source/>Cell. <year>1997</year>;<volume>89</volume>:<fpage>297</fpage>–<lpage>308</lpage>.<pub-id pub-id-type="pmid">9108484</pub-id></mixed-citation>
</ref>
<ref id="CIT0064">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name></person-group>
<article-title>Towards understanding brain-gut-microbiome connections in Alzheimer’s disease</article-title>. <source/>BMC Syst Biol. <year>2016</year>;<volume>10</volume>(<issue>Suppl 3</issue>):<fpage>63</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12918-016-0304-1</pub-id>.<pub-id pub-id-type="pmid">27585440</pub-id></mixed-citation>
</ref>
<ref id="CIT0065">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Chakrabartty</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>PE</given-names></name></person-group>
<article-title>Manipulating the amyloid-beta aggregation pathway with chemical chaperones</article-title>. <source/>J Biol Chem. <year>1999</year>;<volume>274</volume>:<fpage>32970</fpage>–<lpage>32974</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.274.46.32970</pub-id>.<pub-id pub-id-type="pmid">10551864</pub-id></mixed-citation>
</ref>
<ref id="CIT0066">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bose</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>J</given-names></name></person-group>
<article-title>Targeting chaperones, heat shock factor-1, and unfolded protein response: promising therapeutic approaches for neurodegenerative disorders</article-title>. <source/>Ageing Res Rev. <year>2017</year>;<volume>35</volume>:<fpage>155</fpage>–<lpage>175</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arr.2016.09.004</pub-id>.<pub-id pub-id-type="pmid">27702699</pub-id></mixed-citation>
</ref>
<ref id="CIT0067">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name></person-group>
<article-title>The increased release of amino acid neurotransmitters of the primary somatosensory cortical area in rats contributes to remifentanil-induced hyperalgesia and its inhibition by lidocaine</article-title>. <source/>J Pain Res. <year>2018</year>;<volume>11</volume>:<fpage>1521</fpage>–<lpage>1529</lpage>. doi:<pub-id pub-id-type="doi">10.2147/JPR.S168008</pub-id>.<pub-id pub-id-type="pmid">30147356</pub-id></mixed-citation>
</ref>
<ref id="CIT0068">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>O’Toole</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Stanton</surname><given-names>C</given-names></name></person-group>
<article-title>gamma-Aminobutyric acid production by culturable bacteria from the human intestine</article-title>. <source/>J Appl Microbiol. <year>2012</year>;<volume>113</volume>:<fpage>411</fpage>–<lpage>417</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05344.x</pub-id>.<pub-id pub-id-type="pmid">22612585</pub-id></mixed-citation>
</ref>
<ref id="CIT0069">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agus</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Planchais</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sokol</surname><given-names>H</given-names></name></person-group>
<article-title>Gut microbiota regulation of tryptophan metabolism in health and disease</article-title>. <source/>Cell Host Microbe. <year>2018</year>;<volume>23</volume>:<fpage>716</fpage>–<lpage>724</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2018.05.003</pub-id>.<pub-id pub-id-type="pmid">29902437</pub-id></mixed-citation>
</ref>
<ref id="CIT0070">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Van Benschoten</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Cimermancic</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Donia</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Zimmermann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Taketani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ishihara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kashyap</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Fischbach</surname><given-names>MA</given-names></name></person-group>
<article-title>Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine</article-title>. <source/>Cell Host Microbe. <year>2014</year>;<volume>16</volume>:<fpage>495</fpage>–<lpage>503</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2014.09.001</pub-id>.<pub-id pub-id-type="pmid">25263219</pub-id></mixed-citation>
</ref>
<ref id="CIT0071">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yano</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Donaldson</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Shastri</surname><given-names>GG</given-names></name>, <name name-style="western"><surname>Ann</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nagler</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Ismagilov</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Mazmanian</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Hsiao</surname><given-names>EY</given-names></name></person-group>
<article-title>Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis</article-title>. <source/>Cell. <year>2015</year>;<volume>161</volume>:<fpage>264</fpage>–<lpage>276</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.02.047</pub-id>.<pub-id pub-id-type="pmid">25860609</pub-id></mixed-citation>
</ref>
<ref id="CIT0072">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Grenham</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Scully</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Moloney</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Shanahan</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Dinan</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner</article-title>. <source/>Mol Psychiatry. <year>2013</year>;<volume>18</volume>:<fpage>666</fpage>–<lpage>673</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2012.77</pub-id>.<pub-id pub-id-type="pmid">22688187</pub-id></mixed-citation>
</ref>
<ref id="CIT0073">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Desbonnet</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Garrett</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bienenstock</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dinan</surname><given-names>TG</given-names></name></person-group>
<article-title>The probiotic <italic>Bifidobacteria infantis</italic>: an assessment of potential antidepressant properties in the rat</article-title>. <source/>J Psychiatr Res. <year>2008</year>;<volume>43</volume>:<fpage>164</fpage>–<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2008.03.009</pub-id>.<pub-id pub-id-type="pmid">18456279</pub-id></mixed-citation>
</ref>
<ref id="CIT0074">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothhammer</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mascanfroni</surname><given-names>ID</given-names></name>, <name name-style="western"><surname>Bunse</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Takenaka</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Kenison</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Mayo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chao</surname><given-names>-C-C</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Blain</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor</article-title>. <source/>Nat Med. <year>2016</year>;<volume>22</volume>:<fpage>586</fpage>–<lpage>597</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.4106</pub-id>.<pub-id pub-id-type="pmid">27158906</pub-id></mixed-citation>
</ref>
<ref id="CIT0075">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkhalaf</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>KS</given-names></name></person-group>
<article-title>Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms</article-title>. <source/>Chem Biol. <year>2015</year>;<volume>22</volume>:<fpage>317</fpage>–<lpage>328</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chembiol.2015.02.005</pub-id>.<pub-id pub-id-type="pmid">25794436</pub-id></mixed-citation>
</ref>
<ref id="CIT0076">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaszaki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Erces</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Varga</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Szabo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vecsei</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Boros</surname><given-names>M</given-names></name></person-group>
<article-title>Kynurenines and intestinal neurotransmission: the role of N-methyl-D-aspartate receptors</article-title>. <source/>J Neural Transm (Vienna). <year>2012</year>;<volume>119</volume>:<fpage>211</fpage>–<lpage>223</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00702-011-0658-x</pub-id>.<pub-id pub-id-type="pmid">21617892</pub-id></mixed-citation>
</ref>
<ref id="CIT0077">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stone</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Darlington</surname><given-names>LG</given-names></name></person-group>
<article-title>The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders</article-title>. <source/>Br J Pharmacol. <year>2013</year>;<volume>169</volume>:<fpage>1211</fpage>–<lpage>1227</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bph.12230</pub-id>.<pub-id pub-id-type="pmid">23647169</pub-id></mixed-citation>
</ref>
<ref id="CIT0078">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saito</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Markey</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Heyes</surname><given-names>MP</given-names></name></person-group>
<article-title>Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse</article-title>. <source/>Neuroscience. <year>1992</year>;<volume>51</volume>:<fpage>25</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">1465184</pub-id></mixed-citation>
</ref>
<ref id="CIT0079">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fujigaki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>K</given-names></name></person-group>
<article-title>L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences</article-title>. <source/>Neuropharmacology. <year>2017</year>;<volume>112</volume>:<fpage>264</fpage>–<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.01.011</pub-id>.<pub-id pub-id-type="pmid">26767951</pub-id></mixed-citation>
</ref>
<ref id="CIT0080">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LeBlanc</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Milani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>de Giori</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Sesma</surname><given-names>F</given-names></name>, <name name-style="western"><surname>van Sinderen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ventura</surname><given-names>M</given-names></name></person-group>
<article-title>Bacteria as vitamin suppliers to their host: a gut microbiota perspective</article-title>. <source/>Curr Opin Biotechnol. <year>2013</year>;<volume>24</volume>:<fpage>160</fpage>–<lpage>168</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.copbio.2012.08.005</pub-id>.<pub-id pub-id-type="pmid">22940212</pub-id></mixed-citation>
</ref>
<ref id="CIT0081">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Said</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Mohammed</surname><given-names>ZM</given-names></name></person-group>
<article-title>Intestinal absorption of water-soluble vitamins: an update</article-title>. <source/>Curr Opin Gastroenterol. <year>2006</year>;<volume>22</volume>:<fpage>140</fpage>–<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1097/01.mog.0000203870.22706.52</pub-id>.<pub-id pub-id-type="pmid">16462170</pub-id></mixed-citation>
</ref>
<ref id="CIT0082">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merli</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Fink</surname><given-names>J</given-names></name></person-group>
<article-title>Vitamin K and thrombosis</article-title>. <source/>Vitam Horm. <year>2008</year>;<volume>78</volume>:<fpage>265</fpage>–<lpage>279</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0083-6729(07)00013-1</pub-id>.<pub-id pub-id-type="pmid">18374199</pub-id></mixed-citation>
</ref>
<ref id="CIT0083">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McMillan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Perreault</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chance</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Askin</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>J</given-names></name></person-group>
<article-title>Neonatal personnel in Canada</article-title>. <source/>Paediatr Child Health. <year>1997</year>;<volume>2</volume>:<fpage>193</fpage>–<lpage>197</lpage>. doi:<pub-id pub-id-type="doi">10.1093/pch/2.3.193</pub-id>.<pub-id pub-id-type="pmid">20098518</pub-id></mixed-citation>
</ref>
<ref id="CIT0084">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allison</surname><given-names>AC</given-names></name></person-group>
<article-title>The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease</article-title>. <source/>Med Hypotheses. <year>2001</year>;<volume>57</volume>:<fpage>151</fpage>–<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1054/mehy.2001.1307</pub-id>.<pub-id pub-id-type="pmid">11461163</pub-id></mixed-citation>
</ref>
<ref id="CIT0085">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Da Silva</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>Coelho Cerqueira</surname><given-names>E</given-names></name>, <name name-style="western"><surname>de Freitas</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Goncalves</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>LT</given-names></name>, <name name-style="western"><surname>Follmer</surname><given-names>C</given-names></name></person-group>
<article-title>Vitamins K interact with N-terminus alpha-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and alpha-synuclein</article-title>. <source/>Neurochem Int. <year>2013</year>;<volume>62</volume>:<fpage>103</fpage>–<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuint.2012.10.001</pub-id>.<pub-id pub-id-type="pmid">23064431</pub-id></mixed-citation>
</ref>
<ref id="CIT0086">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soutif-Veillon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ferland</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rolland</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Presse</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Feart</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Annweiler</surname><given-names>C</given-names></name></person-group>
<article-title>Increased dietary vitamin K intake is associated with less severe subjective memory complaint among older adults</article-title>. <source/>Maturitas. <year>2016</year>;<volume>93</volume>:<fpage>131</fpage>–<lpage>136</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.maturitas.2016.02.004</pub-id>.<pub-id pub-id-type="pmid">26923488</pub-id></mixed-citation>
</ref>
<ref id="CIT0087">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nie</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>X</given-names></name></person-group>
<article-title>Gradual changes of gut microbiota in weaned miniature Piglets</article-title>. <source/>Front Microbiol. <year>2016</year>;<volume>7</volume>:<fpage>1727</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2016.01727</pub-id>.<pub-id pub-id-type="pmid">27853453</pub-id></mixed-citation>
</ref>
<ref id="CIT0088">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langohr</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Petruch</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Schroth</surname><given-names>G</given-names></name></person-group>
<article-title>Vitamin B 1, B 2 and B 6 deficiency in neurological disorders</article-title>. <source/>J Neurol. <year>1981</year>;<volume>225</volume>:<fpage>95</fpage>–<lpage>108</lpage>.<pub-id pub-id-type="pmid">6164769</pub-id></mixed-citation>
</ref>
<ref id="CIT0089">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finglas</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Wolfe</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Hart</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Dainty</surname><given-names>JR</given-names></name></person-group>
<article-title>Is there more to folates than neural-tube defects?</article-title>
<source/>Proc Nutr Soc. <year>2003</year>;<volume>62</volume>:<fpage>591</fpage>–<lpage>598</lpage>. doi:<pub-id pub-id-type="doi">10.1079/PNS2003271</pub-id>.<pub-id pub-id-type="pmid">14692594</pub-id></mixed-citation>
</ref>
<ref id="CIT0090">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Owen</surname><given-names>RT</given-names></name></person-group>
<article-title>Folate augmentation of antidepressant response</article-title>. <source/>Drugs Today (Barc). <year>2013</year>;<volume>49</volume>:<fpage>791</fpage>–<lpage>798</lpage>. doi:<pub-id pub-id-type="doi">10.1358/dot.2013.49.12.2086138</pub-id>.<pub-id pub-id-type="pmid">24524097</pub-id></mixed-citation>
</ref>
<ref id="CIT0091">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zimmer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Segreti</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Kassiff</surname><given-names>S</given-names></name>, <name name-style="western"><surname>McKain</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Baca</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Rengasamy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hyland</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Walano</surname><given-names>N</given-names></name>, et al</person-group>
<article-title>Neurometabolic disorders: potentially Treatable abnormalities in patients with treatment-refractory depression and suicidal behavior</article-title>. <source/>Am J Psychiatry. <year>2017</year>;<volume>174</volume>:<fpage>42</fpage>–<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ajp.2016.15111500</pub-id>.<pub-id pub-id-type="pmid">27523499</pub-id></mixed-citation>
</ref>
<ref id="CIT0092">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agnew-Blais</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Wassertheil-Smoller</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Hogan</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Coker</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Snetselaar</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Smoller</surname><given-names>JW</given-names></name></person-group>
<article-title>Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the women’s health initiative memory study</article-title>. <source/>J Acad Nutr Diet. <year>2015</year>;<volume>115</volume>:<fpage>231</fpage>–<lpage>241</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jand.2014.07.006</pub-id>.<pub-id pub-id-type="pmid">25201007</pub-id></mixed-citation>
</ref>
<ref id="CIT0093">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Douaud</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Refsum</surname><given-names>H</given-names></name>, <name name-style="western"><surname>de Jager</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Jacoby</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nichols</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>AD</given-names></name></person-group>
<article-title>Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2013</year>;<volume>110</volume>:<fpage>9523</fpage>–<lpage>9528</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1301816110</pub-id>.<pub-id pub-id-type="pmid">23690582</pub-id></mixed-citation>
</ref>
<ref id="CIT0094">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andermann</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Lowell</surname><given-names>BB</given-names></name></person-group>
<article-title>Toward a wiring diagram understanding of appetite control</article-title>. <source/>Neuron. <year>2017</year>;<volume>95</volume>:<fpage>757</fpage>–<lpage>778</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.014</pub-id>.<pub-id pub-id-type="pmid">28817798</pub-id></mixed-citation>
</ref>
<ref id="CIT0095">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brookes</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zagorodnyuk</surname><given-names>VP</given-names></name></person-group>
<article-title>Extrinsic primary afferent signalling in the gut</article-title>. <source/>Nat Rev Gastroenterol Hepatol. <year>2013</year>;<volume>10</volume>:<fpage>286</fpage>–<lpage>296</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrgastro.2013.29</pub-id>.<pub-id pub-id-type="pmid">23438947</pub-id></mixed-citation>
</ref>
<ref id="CIT0096">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gribble</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Reimann</surname><given-names>F</given-names></name></person-group>
<article-title>Enteroendocrine cells: chemosensors in the intestinal epithelium</article-title>. <source/>Annu Rev Physiol. <year>2016</year>;<volume>78</volume>:<fpage>277</fpage>–<lpage>299</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-physiol-021115-105439</pub-id>.<pub-id pub-id-type="pmid">26442437</pub-id></mixed-citation>
</ref>
<ref id="CIT0097">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>GS</given-names></name></person-group>
<article-title>Mechanisms of altered hormone-neurotransmitter action during aging: from receptors to calcium mobilization</article-title>. <source/>Annu Rev Gerontol Geriatr. <year>1990</year>;<volume>10</volume>:<fpage>132</fpage>–<lpage>146</lpage>.<pub-id pub-id-type="pmid">1983283</pub-id></mixed-citation>
</ref>
<ref id="CIT0098">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaelberer</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Bohorquez</surname><given-names>DV</given-names></name></person-group>
<article-title>The now and then of gut-brain signaling</article-title>. <source/>Brain Res. <year>2018</year>;<volume>1693</volume>:<fpage>192</fpage>–<lpage>196</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.brainres.2018.03.027</pub-id>.<pub-id pub-id-type="pmid">29580839</pub-id></mixed-citation>
</ref>
<ref id="CIT0099">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaelberer</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Buchanan</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Barth</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Montoya</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>DV</surname><given-names>Bohórquez</given-names></name></person-group>
<article-title>A gut-brain neural circuit for nutrient sensory transduction</article-title>. <source/>Science. <year>2018</year>;<volume>361:eaat5236. doi:10.1126/science.aat5236</volume>.</mixed-citation>
</ref>
<ref id="CIT0100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauritzen</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Morland</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Puchades</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Holm-Hansen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hagelin</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Lauritzen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Attramadal</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Storm-Mathisen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gjedde</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bergersen</surname><given-names>LH</given-names></name></person-group>
<article-title>Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism</article-title>. <source/>Cereb Cortex. <year>2014</year>;<volume>24</volume>:<fpage>2784</fpage>–<lpage>2795</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bht136</pub-id>.<pub-id pub-id-type="pmid">23696276</pub-id></mixed-citation>
</ref>
<ref id="CIT0101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McAllister</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Krizanac-Bengez</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Macchia</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Naftalin</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Pedley</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Mayberg</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Marroni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Leaman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stanness</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Janigro</surname><given-names>D</given-names></name></person-group>
<article-title>Mechanisms of glucose transport at the blood-brain barrier: an in vitro study</article-title>. <source/>Brain Res. <year>2001</year>;<volume>904</volume>:<fpage>20</fpage>–<lpage>30</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0006-8993(01)02418-0</pub-id>.<pub-id pub-id-type="pmid">11516408</pub-id></mixed-citation>
</ref>
<ref id="CIT0102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kastin</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Akerstrom</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>W</given-names></name></person-group>
<article-title>Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier</article-title>. <source/>J Mol Neurosci. <year>2002</year>;<volume>18</volume>:<fpage>7</fpage>–<lpage>14</lpage>. doi:<pub-id pub-id-type="doi">10.1385/JMN:18:1-2:07</pub-id>.<pub-id pub-id-type="pmid">11931352</pub-id></mixed-citation>
</ref>
<ref id="CIT0103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kishi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hollenberg</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Drucker</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Elmquist</surname><given-names>JK</given-names></name></person-group>
<article-title>Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites</article-title>. <source/>J Neurosci. <year>2003</year>;<volume>23</volume>:<fpage>2939</fpage>–<lpage>2946</lpage>.<pub-id pub-id-type="pmid">12684481</pub-id></mixed-citation>
</ref>
<ref id="CIT0104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kieffer</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>McIntosh</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Pederson</surname><given-names>RA</given-names></name></person-group>
<article-title>Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</article-title>. <source/>Endocrinology. <year>1995</year>;<volume>136</volume>:<fpage>3585</fpage>–<lpage>3596</lpage>. doi:<pub-id pub-id-type="doi">10.1210/endo.136.8.7628397</pub-id>.<pub-id pub-id-type="pmid">7628397</pub-id></mixed-citation>
</ref>
<ref id="CIT0105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neunlist</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schemann</surname><given-names>M</given-names></name></person-group>
<article-title>Nutrient-induced changes in the phenotype and function of the enteric nervous system</article-title>. <source/>J Physiol. <year>2014</year>;<volume>592</volume>:<fpage>2959</fpage>–<lpage>2965</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2014.272948</pub-id>.<pub-id pub-id-type="pmid">24907307</pub-id></mixed-citation>
</ref>
<ref id="CIT0106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abot</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cani</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Knauf</surname><given-names>C</given-names></name></person-group>
<article-title>Impact of intestinal peptides on the enteric nervous system: novel approaches to control glucose metabolism and food intake</article-title>. <source/>Front Endocrinol (Lausanne). <year>2018</year>;<volume>9</volume>:<fpage>328</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fendo.2018.00420</pub-id>.<pub-id pub-id-type="pmid">29988396</pub-id></mixed-citation>
</ref>
<ref id="CIT0107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Alhadeff</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Betley</surname><given-names>JN</given-names></name></person-group>
<article-title>Nutritive, post-ingestive signals are the primary regulators of AgRP neuron activity</article-title>. <source/>Cell Rep. <year>2017</year>;<volume>21</volume>:<fpage>2724</fpage>–<lpage>2736</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2017.11.036</pub-id>.<pub-id pub-id-type="pmid">29212021</pub-id></mixed-citation>
</ref>
<ref id="CIT0108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dockray</surname><given-names>GJ</given-names></name></person-group>
<article-title>Enteroendocrine cell signalling via the vagus nerve</article-title>. <source/>Curr Opin Pharmacol. <year>2013</year>;<volume>13</volume>:<fpage>954</fpage>–<lpage>958</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coph.2013.09.007</pub-id>.<pub-id pub-id-type="pmid">24064396</pub-id></mixed-citation>
</ref>
<ref id="CIT0109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nohr</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Egerod</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Christiansen</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Gille</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Offermanns</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Møller</surname><given-names>M</given-names></name></person-group>
<article-title>Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia</article-title>. <source/>Neuroscience. <year>2015</year>;<volume>290</volume>:<fpage>126</fpage>–<lpage>137</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.01.040</pub-id>.<pub-id pub-id-type="pmid">25637492</pub-id></mixed-citation>
</ref>
<ref id="CIT0110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poole</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Godfrey</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cattaruzza</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cottrell</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Kirkland</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Pelayo</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Bunnett</surname><given-names>NW</given-names></name>, <name name-style="western"><surname>CU</surname><given-names>Corvera</given-names></name>, et al</person-group>
<article-title>Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system</article-title>. <source/>Neurogastroenterol Motil. <year>2010</year>;<volume>22</volume>(<issue>814–25</issue>):<fpage>e227</fpage>–<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2982.2010.01487.x</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soret</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Chevalier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>De Coppet</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Poupeau</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Derkinderen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Segain</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Neunlist</surname><given-names>M</given-names></name></person-group>
<article-title>Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats</article-title>. <source/>Gastroenterology. <year>2010</year>;<volume>138</volume>:<fpage>1772</fpage>–<lpage>1782</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2010.01.053</pub-id>.<pub-id pub-id-type="pmid">20152836</pub-id></mixed-citation>
</ref>
<ref id="CIT0112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vincent</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Raybould</surname><given-names>HE</given-names></name></person-group>
<article-title>Intestinal glucose-induced calcium-calmodulin kinase signaling in the gut-brain axis in awake rats</article-title>. <source/>Neurogastroenterol Motil. <year>2011</year>;<volume>23</volume>:<fpage>e282</fpage>–<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2982.2011.01673.x</pub-id>.<pub-id pub-id-type="pmid">21303432</pub-id></mixed-citation>
</ref>
<ref id="CIT0113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohorquez</surname><given-names>DV</given-names></name>, <name name-style="western"><surname>Shahid</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Erdmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kreger</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Calakos</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Liddle</surname><given-names>RA</given-names></name></person-group>
<article-title>Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells</article-title>. <source/>J Clin Invest. <year>2015</year>;<volume>125</volume>:<fpage>782</fpage>–<lpage>786</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI78361</pub-id>.<pub-id pub-id-type="pmid">25555217</pub-id></mixed-citation>
</ref>
<ref id="CIT0114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schretter</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Vielmetter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bartos</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Marka</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Marka</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Argade</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>
<article-title>A gut microbial factor modulates locomotor behaviour in <italic>Drosophila</italic></article-title>. <source/>Nature. <year>2018</year>;<volume>563</volume>:<fpage>402</fpage>–<lpage>406</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-018-0634-9</pub-id>.<pub-id pub-id-type="pmid">30356215</pub-id></mixed-citation>
</ref>
<ref id="CIT0115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Yue</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>H-T</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>X-M</given-names></name>, <name name-style="western"><surname>He</surname><given-names>-L-L</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Q-L</given-names></name>, et al</person-group>
<article-title>Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis</article-title>. <source/>World J Gastroenterol. <year>2017</year>;<volume>23</volume>:<fpage>999</fpage>–<lpage>1009</lpage>. doi:<pub-id pub-id-type="doi">10.3748/wjg.v23.i6.999</pub-id>.<pub-id pub-id-type="pmid">28246473</pub-id></mixed-citation>
</ref>
<ref id="CIT0116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mark</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>DW</given-names></name></person-group>
<article-title>Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure</article-title>. <source/>Life Sci. <year>1999</year>;<volume>64</volume>:<fpage>1941</fpage>–<lpage>1953</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0024-3205(99)00139-3</pub-id>.<pub-id pub-id-type="pmid">10353592</pub-id></mixed-citation>
</ref>
<ref id="CIT0117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomsen</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Birkelund</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Burkhart</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stensballe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moos</surname><given-names>T</given-names></name></person-group>
<article-title>Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood-brain barrier</article-title>. <source/>J Neurochem. <year>2017</year>;<volume>140</volume>:<fpage>741</fpage>–<lpage>754</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jnc.13747</pub-id>.<pub-id pub-id-type="pmid">27456748</pub-id></mixed-citation>
</ref>
<ref id="CIT0118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perry</surname><given-names>VH</given-names></name></person-group>
<article-title>Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain</article-title>. <source/>Brain Behav Immun. <year>2007</year>;<volume>21</volume>:<fpage>45</fpage>–<lpage>46</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2006.08.004</pub-id>.<pub-id pub-id-type="pmid">17011745</pub-id></mixed-citation>
</ref>
<ref id="CIT0119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>ZS</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Juang</surname><given-names>JL</given-names></name></person-group>
<article-title>Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in <italic>Drosophila</italic></article-title>. <source/>Nat Commun. <year>2017</year>;<volume>8</volume>:<fpage>24</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-017-00040-6</pub-id>.<pub-id pub-id-type="pmid">28634323</pub-id></mixed-citation>
</ref>
<ref id="CIT0120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Fairless</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Maier</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Liermann</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Pichi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Eisel</surname><given-names>ULM</given-names></name>, <name name-style="western"><surname>Kontermann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Herrmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Weksler</surname><given-names>B</given-names></name>, et al</person-group>
<article-title>Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis</article-title>. <source/>Sci Rep. <year>2018</year>;<volume>8</volume>:<fpage>13628</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-018-31957-7</pub-id>.<pub-id pub-id-type="pmid">30206422</pub-id></mixed-citation>
</ref>
<ref id="CIT0121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gill</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kulkarni</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pasricha</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Habtezion</surname><given-names>A</given-names></name></person-group>
<article-title>Age-dependent shift in macrophage polarisation causes inflammation-mediated degeneration of enteric nervous system</article-title>. <source/>Gut. <year>2018</year>;<volume>67</volume>:<fpage>827</fpage>–<lpage>836</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2016-312940</pub-id>.<pub-id pub-id-type="pmid">28228489</pub-id></mixed-citation>
</ref>
<ref id="CIT0122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenbaum</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schick</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Wollborn</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Heider</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Scholz</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Cecil</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Niesler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hirrlinger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Walles</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Metzger</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Activation of myenteric Glia during acute inflammation in vitro and in vivo</article-title>. <source/>PLoS One. <year>2016</year>;<volume>11</volume>:<fpage>e0151335</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0151335</pub-id>.<pub-id pub-id-type="pmid">26964064</pub-id></mixed-citation>
</ref>
<ref id="CIT0123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkahtani</surname><given-names>SH</given-names></name></person-group>
<article-title>The steroidal Na+/K+ ATPase inhibitor 3-[(R)-3-pyrrolidinyl]oxime derivative (3-R-POD) induces potent pro-apoptotic responses in colonic tumor cells</article-title>. <source/>Anticancer Res. <year>2014</year>;<volume>34</volume>:<fpage>2967</fpage>–<lpage>2971</lpage>.<pub-id pub-id-type="pmid">24922661</pub-id></mixed-citation>
</ref>
<ref id="CIT0124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kabouridis</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Lasrado</surname><given-names>R</given-names></name>, <name name-style="western"><surname>McCallum</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chng</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Snippert</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Clevers</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Pettersson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pachnis</surname><given-names>V</given-names></name></person-group>
<article-title>The gut microbiota keeps enteric glial cells on the move; prospective roles of the gut epithelium and immune system</article-title>. <source/>Gut Microbes. <year>2015</year>;<volume>6</volume>:<fpage>398</fpage>–<lpage>403</lpage>. doi:<pub-id pub-id-type="doi">10.1080/19490976.2015.1109767</pub-id>.<pub-id pub-id-type="pmid">26558327</pub-id></mixed-citation>
</ref>
<ref id="CIT0125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibiza</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Garcia-Cassani</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ribeiro</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Marques</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Misic</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Bartow-McKenney</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Larson</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Pavan</surname><given-names>WJ</given-names></name>, et al</person-group>
<article-title>Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence</article-title>. <source/>Nature. <year>2016</year>;<volume>535</volume>:<fpage>440</fpage>–<lpage>443</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature18644</pub-id>.<pub-id pub-id-type="pmid">27409807</pub-id></mixed-citation>
</ref>
<ref id="CIT0126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jackerott</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Larsson</surname><given-names>LI</given-names></name></person-group>
<article-title>Immunocytochemical localization of the NPY/PYY Y1 receptor in enteric neurons, endothelial cells, and endocrine-like cells of the rat intestinal tract</article-title>. <source/>J Histochem Cytochem. <year>1997</year>;<volume>45</volume>:<fpage>1643</fpage>–<lpage>1650</lpage>. doi:<pub-id pub-id-type="doi">10.1177/002215549704501207</pub-id>.<pub-id pub-id-type="pmid">9389767</pub-id></mixed-citation>
</ref>
<ref id="CIT0127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terry</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Margolis</surname><given-names>KG</given-names></name></person-group>
<article-title>Serotonergic mechanisms regulating the GI tract: experimental evidence and therapeutic relevance</article-title>. <source/>Handb Exp Pharmacol. <year>2017</year>;<volume>239</volume>:<fpage>319</fpage>–<lpage>342</lpage>. doi:<pub-id pub-id-type="doi">10.1007/164_2016_103</pub-id>.<pub-id pub-id-type="pmid">28035530</pub-id></mixed-citation>
</ref>
<ref id="CIT0128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Branchek</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tamir</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gershon</surname><given-names>MD</given-names></name></person-group>
<article-title>Specific antagonism of enteric neural serotonin receptors by dipeptides of 5-hydroxytryptophan: evidence that serotonin is a mediator of slow synaptic excitation in the myenteric plexus</article-title>. <source/>J Neurosci. <year>1985</year>;<volume>5</volume>:<fpage>1769</fpage>–<lpage>1780</lpage>.<pub-id pub-id-type="pmid">3874933</pub-id></mixed-citation>
</ref>
<ref id="CIT0129">
<label>129.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Zaidi</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group>
<article-title>5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor</article-title>. <source/>Bioorg Med Chem Lett. <year>2014</year>;<volume>24</volume>:<fpage>1489</fpage>–<lpage>1492</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bmcl.2014.02.029</pub-id>.<pub-id pub-id-type="pmid">24582985</pub-id></mixed-citation>
</ref>
<ref id="CIT0130">
<label>130.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Vadder</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Grasset</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Manneras Holm</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Karsenty</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Macpherson</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Olofsson</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Bäckhed</surname><given-names>F</given-names></name></person-group>
<article-title>Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2018</year>;<volume>115</volume>:<fpage>6458</fpage>–<lpage>6463</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1720017115</pub-id>.<pub-id pub-id-type="pmid">29866843</pub-id></mixed-citation>
</ref>
<ref id="CIT0131">
<label>131.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name></person-group>
<article-title>Neurotransmitter receptors and cognitive dysfunction in Alzheimer’s disease and Parkinson’s disease</article-title>. <source/>Prog Neurobiol. <year>2012</year>;<volume>97</volume>:<fpage>1</fpage>–<lpage>13</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pneurobio.2012.02.002</pub-id>.<pub-id pub-id-type="pmid">22387368</pub-id></mixed-citation>
</ref>
<ref id="CIT0132">
<label>132.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barajon</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Serrao</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Arnaboldi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Opizzi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ripamonti</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Balsari</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rumio</surname><given-names>C</given-names></name></person-group>
<article-title>Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia</article-title>. <source/>J Histochem Cytochem. <year>2009</year>;<volume>57</volume>:<fpage>1013</fpage>–<lpage>1023</lpage>. doi:<pub-id pub-id-type="doi">10.1369/jhc.2009.953539</pub-id>.<pub-id pub-id-type="pmid">19546475</pub-id></mixed-citation>
</ref>
<ref id="CIT0133">
<label>133.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brun</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Giron</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Qesari</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Porzionato</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Caputi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Zoppellaro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Banzato</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grillo</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Spagnol</surname><given-names>L</given-names></name>, <name name-style="western"><surname>De Caro</surname><given-names>R</given-names></name>, et al</person-group>
<article-title>Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system</article-title>. <source/>Gastroenterology. <year>2013</year>;<volume>145</volume>:<fpage>1323</fpage>–<lpage>1333</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2013.08.047</pub-id>.<pub-id pub-id-type="pmid">23994200</pub-id></mixed-citation>
</ref>
<ref id="CIT0134">
<label>134.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spielman</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Klegeris</surname><given-names>A</given-names></name></person-group>
<article-title>Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases</article-title>. <source/>Neurochem Int. <year>2018</year>;<volume>120</volume>:<fpage>149</fpage>–<lpage>163</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuint.2018.08.005</pub-id>.<pub-id pub-id-type="pmid">30114473</pub-id></mixed-citation>
</ref>
<ref id="CIT0135">
<label>135.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hyland</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>A Gut Feeling about GABA: focus on GABA(B) Receptors</article-title>. <source/>Front Pharmacol. <year>2010</year>;<volume>1</volume>:<fpage>124</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphar.2010.00124</pub-id>.<pub-id pub-id-type="pmid">21833169</pub-id></mixed-citation>
</ref>
<ref id="CIT0136">
<label>136.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>XB</given-names></name>, <name name-style="western"><surname>Hollocher</surname><given-names>TC</given-names></name></person-group>
<article-title>Reduction of nitrite to nitric oxide by enteric bacteria</article-title>. <source/>Biochem Biophys Res Commun. <year>1988</year>;<volume>157</volume>:<fpage>106</fpage>–<lpage>108</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0006-291x(88)80018-4</pub-id>.<pub-id pub-id-type="pmid">3058123</pub-id></mixed-citation>
</ref>
<ref id="CIT0137">
<label>137.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stanaszek</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Snell</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>O’Neill</surname><given-names>JJ</given-names></name></person-group>
<article-title>Isolation, extraction, and measurement of acetylcholine from <italic>Lactobacillus plantarum</italic></article-title>. <source/>Appl Environ Microbiol. <year>1977</year>;<volume>34</volume>:<fpage>237</fpage>–<lpage>239</lpage>.<pub-id pub-id-type="pmid">907345</pub-id></mixed-citation>
</ref>
<ref id="CIT0138">
<label>138.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsavkelova</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Botvinko</surname><given-names>IV</given-names></name>, <name name-style="western"><surname>Kudrin</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Oleskin</surname><given-names>AV</given-names></name></person-group>
<article-title>Detection of neurotransmitter amines in microorganisms with the use of high-performance liquid chromatography</article-title>. <source/>Dokl Biochem. <year>2000</year>;<volume>372</volume>:<fpage>115</fpage>–<lpage>117</lpage>.<pub-id pub-id-type="pmid">10935181</pub-id></mixed-citation>
</ref>
<ref id="CIT0139">
<label>139.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Özoğul</surname><given-names>F</given-names></name></person-group>
<article-title>Production of biogenic amines by <italic>Morganella morganii</italic>, <italic>Klebsiella pneumoniae</italic> and <italic>Hafnia alvei</italic> using a rapid HPLC method</article-title>. <source/>Eur Food Res Technol. <year>2004</year>;<volume>219</volume>:<fpage>465</fpage>–<lpage>469</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00217-004-0988-0</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0140">
<label>140.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dinan</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Stanton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>Psychobiotics: a novel class of psychotropic</article-title>. <source/>Biol Psychiatry. <year>2013</year>;<volume>74</volume>:<fpage>720</fpage>–<lpage>726</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.05.001</pub-id>.<pub-id pub-id-type="pmid">23759244</pub-id></mixed-citation>
</ref>
<ref id="CIT0141">
<label>141.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bambury</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sandhu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cryan</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Dinan</surname><given-names>TG</given-names></name></person-group>
<article-title>Finding the needle in the haystack: systematic identification of psychobiotics</article-title>. <source/>Br J Pharmacol. <year>2018</year>;<volume>175</volume>:<fpage>4430</fpage>–<lpage>4438</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bph.14127</pub-id>.<pub-id pub-id-type="pmid">29243233</pub-id></mixed-citation>
</ref>
<ref id="CIT0142">
<label>142.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skelly</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Hennessy</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Dansereau</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Cunningham</surname><given-names>C</given-names></name></person-group>
<article-title>A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1beta, [corrected] TNF-alpha and IL-6 challenges in C57BL/6 mice</article-title>. <source/>PLoS One. <year>2013</year>;<volume>8</volume>:<fpage>e69123</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0069123</pub-id>.<pub-id pub-id-type="pmid">23840908</pub-id></mixed-citation>
</ref>
<ref id="CIT0143">
<label>143.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morton</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Meek</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>MW</given-names></name></person-group>
<article-title>Neurobiology of food intake in health and disease</article-title>. <source/>Nat Rev Neurosci. <year>2014</year>;<volume>15</volume>:<fpage>367</fpage>–<lpage>378</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn3745</pub-id>.<pub-id pub-id-type="pmid">24840801</pub-id></mixed-citation>
</ref>
<ref id="CIT0144">
<label>144.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benakis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Brea</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Caballero</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Faraco</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sita</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Racchumi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ling</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pamer</surname><given-names>EG</given-names></name>, et al</person-group>
<article-title>Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells</article-title>. <source/>Nat Med. <year>2016</year>;<volume>22</volume>:<fpage>516</fpage>–<lpage>523</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.4068</pub-id>.<pub-id pub-id-type="pmid">27019327</pub-id></mixed-citation>
</ref>
<ref id="CIT0145">
<label>145.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banks</surname><given-names>WA</given-names></name></person-group>
<article-title>Brain meets body: the blood-brain barrier as an endocrine interface</article-title>. <source/>Endocrinology. <year>2012</year>;<volume>153</volume>:<fpage>4111</fpage>–<lpage>4119</lpage>. doi:<pub-id pub-id-type="doi">10.1210/en.2012-1435</pub-id>.<pub-id pub-id-type="pmid">22778219</pub-id></mixed-citation>
</ref>
<ref id="CIT0146">
<label>146.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Louveau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Herz</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Alme</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Salvador</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>MQ</given-names></name>, <name name-style="western"><surname>Viar</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Herod</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Knopp</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Setliff</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Lupi</surname><given-names>AL</given-names></name>, et al</person-group>
<article-title>CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature</article-title>. <source/>Nat Neurosci. <year>2018</year>;<volume>21</volume>:<fpage>1380</fpage>–<lpage>1391</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41593-018-0227-9</pub-id>.<pub-id pub-id-type="pmid">30224810</pub-id></mixed-citation>
</ref>
<ref id="CIT0147">
<label>147.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herisson</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Frodermann</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Courties</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rohde</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Vandoorne</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wojtkiewicz</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Masson</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Vinegoni</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration</article-title>. <source/>Nat Neurosci. <year>2018</year>;<volume>21</volume>:<fpage>1209</fpage>–<lpage>1217</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41593-018-0213-2</pub-id>.<pub-id pub-id-type="pmid">30150661</pub-id></mixed-citation>
</ref>
<ref id="CIT0148">
<label>148.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Janowitz</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Metea</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Asquith</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Karstens</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rosenbaum</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>P</given-names></name></person-group>
<article-title>Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine</article-title>. <source/>Sci Rep. <year>2017</year>;<volume>7</volume>:<fpage>11745</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-017-12163-3</pub-id>.<pub-id pub-id-type="pmid">28924192</pub-id></mixed-citation>
</ref>
<ref id="CIT0149">
<label>149.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braak</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ghebremedhin</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rub</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Bratzke</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Del Tredici</surname><given-names>K</given-names></name></person-group>
<article-title>Stages in the development of Parkinson’s disease-related pathology</article-title>. <source/>Cell Tissue Res. <year>2004</year>;<volume>318</volume>:<fpage>121</fpage>–<lpage>134</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00441-004-0956-9</pub-id>.<pub-id pub-id-type="pmid">15338272</pub-id></mixed-citation>
</ref>
<ref id="CIT0150">
<label>150.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peelaerts</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Bousset</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Van der Perren</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moskalyuk</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pulizzi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Giugliano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Van Den Haute</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Melki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Baekelandt</surname><given-names>V</given-names></name></person-group>
<article-title>alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration</article-title>. <source/>Nature. <year>2015</year>;<volume>522</volume>:<fpage>340</fpage>–<lpage>344</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature14547</pub-id>.<pub-id pub-id-type="pmid">26061766</pub-id></mixed-citation>
</ref>
<ref id="CIT0151">
<label>151.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breen</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Halliday</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>AE</given-names></name></person-group>
<article-title>Gut-brain axis and the spread of alpha-synuclein pathology: vagal highway or dead end?</article-title>
<source/>Mov Disord. <year>2019</year>;<volume>34</volume>:<fpage>307</fpage>–<lpage>316</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.27556</pub-id>.<pub-id pub-id-type="pmid">30653258</pub-id></mixed-citation>
</ref>
<ref id="CIT0152">
<label>152.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan-Montojo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Anichtchik</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Dening</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Knels</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pursche</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gille</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Spillantini</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Reichmann</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice</article-title>. <source/>PLoS One. <year>2010</year>;<volume>5</volume>:<fpage>e8762</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0008762</pub-id>.<pub-id pub-id-type="pmid">20098733</pub-id></mixed-citation>
</ref>
<ref id="CIT0153">
<label>153.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan-Montojo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Schwarz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Winkler</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Arnhold</surname><given-names>M</given-names></name>, <name name-style="western"><surname>O’Sullivan</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Pal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Said</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marsico</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Verbavatz</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Rodrigo-Angulo</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice</article-title>. <source/>Sci Rep. <year>2012</year>;<volume>2</volume>:<fpage>898</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep00386</pub-id>.<pub-id pub-id-type="pmid">23205266</pub-id></mixed-citation>
</ref>
<ref id="CIT0154">
<label>154.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holmqvist</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chutna</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Bousset</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Aldrin-Kirk</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Bjorklund</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z-Y</given-names></name>, <name name-style="western"><surname>Roybon</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Melki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J-Y</given-names></name></person-group>
<article-title>Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats</article-title>. <source/>Acta Neuropathol. <year>2014</year>;<volume>128</volume>:<fpage>805</fpage>–<lpage>820</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00401-014-1343-6</pub-id>.<pub-id pub-id-type="pmid">25296989</pub-id></mixed-citation>
</ref>
<ref id="CIT0155">
<label>155.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uemura</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yagi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Uemura</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Hatanaka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yamakado</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>R</given-names></name></person-group>
<article-title>Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve</article-title>. <source/>Mol Neurodegener. <year>2018</year>;<volume>13</volume>:<fpage>21</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13024-018-0257-5</pub-id>.<pub-id pub-id-type="pmid">29751824</pub-id></mixed-citation>
</ref>
<ref id="CIT0156">
<label>156.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hiniker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Nussbaum</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Liddle</surname><given-names>RA</given-names></name></person-group>
<article-title>alpha-Synuclein in gut endocrine cells and its implications for Parkinson’s disease</article-title>. <source/>JCI Insight. <year>2017</year>;<fpage>2:e92295. doi:10.1172/jci.insight.92295</fpage>.</mixed-citation>
</ref>
<ref id="CIT0157">
<label>157.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rey</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Petit</surname><given-names>GH</given-names></name>, <name name-style="western"><surname>Bousset</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Melki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Brundin</surname><given-names>P</given-names></name></person-group>
<article-title>Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice</article-title>. <source/>Acta Neuropathol. <year>2013</year>;<volume>126</volume>:<fpage>555</fpage>–<lpage>573</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00401-013-1160-3</pub-id>.<pub-id pub-id-type="pmid">23925565</pub-id></mixed-citation>
</ref>
<ref id="CIT0158">
<label>158.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Svensson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Horvath-Puho</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Thomsen</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Djurhuus</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Borghammer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sørensen</surname><given-names>HT</given-names></name></person-group>
<article-title>Vagotomy and subsequent risk of Parkinson’s disease</article-title>. <source/>Ann Neurol. <year>2015</year>;<volume>78</volume>:<fpage>522</fpage>–<lpage>529</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.24448</pub-id>.<pub-id pub-id-type="pmid">26031848</pub-id></mixed-citation>
</ref>
<ref id="CIT0159">
<label>159.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Tillander</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ludvigsson</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Ekbom</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Svenningsson</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wirdefeldt</surname><given-names>K</given-names></name></person-group>
<article-title>Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study</article-title>. <source/>Neurology. <year>2017</year>;<volume>88</volume>:<fpage>1996</fpage>–<lpage>2002</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000003961</pub-id>.<pub-id pub-id-type="pmid">28446653</pub-id></mixed-citation>
</ref>
<ref id="CIT0160">
<label>160.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>IK</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Kao</surname><given-names>C-H</given-names></name></person-group>
<article-title>Dementia and vagotomy in Taiwan: a population-based cohort study</article-title>. <source/>BMJ Open. <year>2018</year>;<volume>8</volume>:<fpage>e019582</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2017-019582</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0161">
<label>161.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guinane</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Tadrous</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fouhy</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Dempsey</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cotter</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Stanton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>RP</given-names></name></person-group>
<article-title>Microbial composition of human appendices from patients following appendectomy</article-title>. <source/>MBio. <year>2013</year>;<volume>4:e00366-12. doi:10.1128/mBio.00366-12</volume>.</mixed-citation>
</ref>
<ref id="CIT0162">
<label>162.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Schlossmacher</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Woulfe</surname><given-names>JM</given-names></name></person-group>
<article-title>Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects</article-title>. <source/>Mov Disord. <year>2014</year>;<volume>29</volume>:<fpage>991</fpage>–<lpage>998</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.25779</pub-id>.<pub-id pub-id-type="pmid">24352892</pub-id></mixed-citation>
</ref>
<ref id="CIT0163">
<label>163.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendes</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Goncalves</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vila-Cha</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Moreira</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Fernandes</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Damasio</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Teixeira-Pinto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Taipa</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lima</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Cavaco</surname><given-names>S</given-names></name></person-group>
<article-title>Appendectomy may delay Parkinson’s disease Onset</article-title>. <source/>Mov Disord. <year>2015</year>;<volume>30</volume>:<fpage>1404</fpage>–<lpage>1407</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.26311</pub-id>.<pub-id pub-id-type="pmid">26228745</pub-id></mixed-citation>
</ref>
<ref id="CIT0164">
<label>164.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yilmaz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bayram</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ulukan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Altinok</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Akbostanci</surname><given-names>MC</given-names></name></person-group>
<article-title>Appendectomy history is not related to Parkinson’s Disease</article-title>. <source/>J Parkinsons Dis. <year>2017</year>;<volume>7</volume>:<fpage>347</fpage>–<lpage>352</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JPD-171071</pub-id>.<pub-id pub-id-type="pmid">28387683</pub-id></mixed-citation>
</ref>
<ref id="CIT0165">
<label>165.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marras</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Austin</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Urbach</surname><given-names>DR</given-names></name></person-group>
<article-title>Appendectomy in mid and later life and risk of Parkinson’s disease: a population-based study</article-title>. <source/>Mov Disord. <year>2016</year>;<volume>31</volume>:<fpage>1243</fpage>–<lpage>1247</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.26670</pub-id>.<pub-id pub-id-type="pmid">27241338</pub-id></mixed-citation>
</ref>
<ref id="CIT0166">
<label>166.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Svensson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Horvath-Puho</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Stokholm</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Sorensen</surname><given-names>HT</given-names></name>, <name name-style="western"><surname>Henderson</surname><given-names>VW</given-names></name>, <name name-style="western"><surname>Borghammer</surname><given-names>P</given-names></name></person-group>
<article-title>Appendectomy and risk of Parkinson’s disease: a nationwide cohort study with more than 10 years of follow-up</article-title>. <source/>Mov Disord. <year>2016</year>;<volume>31</volume>:<fpage>1918</fpage>–<lpage>1922</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.26761</pub-id>.<pub-id pub-id-type="pmid">27621223</pub-id></mixed-citation>
</ref>
<ref id="CIT0167">
<label>167.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Stribinskis</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Rane</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Demuth</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Gozal</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Jagadapillai</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Choe</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Shivakumar</surname><given-names>B</given-names></name>, et al</person-group>
<article-title>Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and <italic>Caenorhabditis elegans</italic></article-title>. <source/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>34477</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep34477</pub-id>.<pub-id pub-id-type="pmid">27708338</pub-id></mixed-citation>
</ref>
<ref id="CIT0168">
<label>168.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Roberfroid</surname><given-names>MB</given-names></name></person-group>
<article-title>Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics</article-title>. <source/>J Nutr. <year>1995</year>;<volume>125</volume>:<fpage>1401</fpage>–<lpage>1412</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jn/125.6.1401</pub-id>.<pub-id pub-id-type="pmid">7782892</pub-id></mixed-citation>
</ref>
<ref id="CIT0169">
<label>169.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberfroid</surname><given-names>M</given-names></name></person-group>
<article-title>Probiotics and prebiotics: why should the medical community pay attention?</article-title>
<source/>Drug Discov Today. <year>2003</year>;<volume>8</volume>:<fpage>1107</fpage>–<lpage>1108</lpage>.<pub-id pub-id-type="pmid">14678734</pub-id></mixed-citation>
</ref>
<ref id="CIT0170">
<label>170.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iannitti</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Palmieri</surname><given-names>B</given-names></name></person-group>
<article-title>Therapeutical use of probiotic formulations in clinical practice</article-title>. <source/>Clin Nutr. <year>2010</year>;<volume>29</volume>:<fpage>701</fpage>–<lpage>725</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clnu.2010.05.004</pub-id>.<pub-id pub-id-type="pmid">20576332</pub-id></mixed-citation>
</ref>
<ref id="CIT0171">
<label>171.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bindels</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Delzenne</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Cani</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Walter</surname><given-names>J</given-names></name></person-group>
<article-title>Towards a more comprehensive concept for prebiotics</article-title>. <source/>Nat Rev Gastroenterol Hepatol. <year>2015</year>;<volume>12</volume>:<fpage>303</fpage>–<lpage>310</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrgastro.2015.47</pub-id>.<pub-id pub-id-type="pmid">25824997</pub-id></mixed-citation>
</ref>
<ref id="CIT0172">
<label>172.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savignac</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Corona</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Tzortzis</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Burnet</surname><given-names>PWJ</given-names></name></person-group>
<article-title>Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine</article-title>. <source/>Neurochem Int. <year>2013</year>;<volume>63</volume>:<fpage>756</fpage>–<lpage>764</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuint.2013.10.006</pub-id>.<pub-id pub-id-type="pmid">24140431</pub-id></mixed-citation>
</ref>
<ref id="CIT0173">
<label>173.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kao</surname><given-names>A-C-C</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Anthony</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Lennox</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Burnet</surname><given-names>PW</given-names></name></person-group>
<article-title>Prebiotic reduction of brain histone deacetylase (HDAC) activity and olanzapine-mediated weight gain in rats, are acetate independent</article-title>. <source/>Neuropharmacology. <year>2019</year>;<volume>150</volume>:<fpage>184</fpage>–<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2019.02.014</pub-id>.<pub-id pub-id-type="pmid">30763656</pub-id></mixed-citation>
</ref>
<ref id="CIT0174">
<label>174.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mika</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gaffney</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Roller</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hills</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bouchet</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Hulen</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Chichlowski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Berg</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Fleshner</surname><given-names>M</given-names></name></person-group>
<article-title>Feeding the developing brain: juvenile rats fed diet rich in prebiotics and bioactive milk fractions exhibit reduced anxiety-related behavior and modified gene expression in emotion circuits</article-title>. <source/>Neurosci Lett. <year>2018</year>;<volume>677</volume>:<fpage>103</fpage>–<lpage>109</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neulet.2018.01.052</pub-id>.<pub-id pub-id-type="pmid">29409860</pub-id></mixed-citation>
</ref>
<ref id="CIT0175">
<label>175.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Cossío</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Fourrier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sauvant</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Everard</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Capuron</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cani</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Layé</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Castanon</surname><given-names>N</given-names></name></person-group>
<article-title>Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome</article-title>. <source/>Brain Behav Immun. <year>2017</year>;<volume>64</volume>:<fpage>33</fpage>–<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2016.12.022</pub-id>.<pub-id pub-id-type="pmid">28027925</pub-id></mixed-citation>
</ref>
<ref id="CIT0176">
<label>176.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burokas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arboleya</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Moloney</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>VL</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stanton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dinan</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice</article-title>. <source/>Biol Psychiatry. <year>2017</year>;<volume>82</volume>:<fpage>472</fpage>–<lpage>487</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2016.12.031</pub-id>.<pub-id pub-id-type="pmid">28242013</pub-id></mixed-citation>
</ref>
<ref id="CIT0177">
<label>177.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crumeyrolle-Arias</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jaglin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bruneau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vancassel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cardona</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dauge</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Naudon</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rabot</surname><given-names>S</given-names></name></person-group>
<article-title>Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats</article-title>. <source/>Psychoneuroendocrinology. <year>2014</year>;<volume>42</volume>:<fpage>207</fpage>–<lpage>217</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.01.014</pub-id>.<pub-id pub-id-type="pmid">24636517</pub-id></mixed-citation>
</ref>
<ref id="CIT0178">
<label>178.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Chida</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Aiba</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sonoda</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oyama</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>XN</given-names></name>, <name name-style="western"><surname>Kubo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Koga</surname><given-names>Y</given-names></name></person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>. <source/>J Physiol. <year>2004</year>;<volume>558</volume>:<fpage>263</fpage>–<lpage>275</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id>.<pub-id pub-id-type="pmid">15133062</pub-id></mixed-citation>
</ref>
<ref id="CIT0179">
<label>179.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kao</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Spitzer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Anthony</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Lennox</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Burnet</surname><given-names>PWJ</given-names></name></person-group>
<article-title>Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota</article-title>. <source/>Transl Psychiatry. <year>2018</year>;<volume>8</volume>:<fpage>66</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41398-018-0116-8</pub-id>.<pub-id pub-id-type="pmid">29540664</pub-id></mixed-citation>
</ref>
<ref id="CIT0180">
<label>180.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cowen</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Harmer</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Tzortzis</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Errington</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Burnet</surname><given-names>PW</given-names></name></person-group>
<article-title>Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers</article-title>. <source/>Psychopharmacology (Berl). <year>2015</year>;<volume>232</volume>:<fpage>1793</fpage>–<lpage>1801</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00213-014-3810-0</pub-id>.<pub-id pub-id-type="pmid">25449699</pub-id></mixed-citation>
</ref>
<ref id="CIT0181">
<label>181.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Den Berg</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Westerbeek</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Broring-Starre</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Garssen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van Elburg</surname><given-names>RM</given-names></name></person-group>
<article-title>Neurodevelopment of preterm infants at 24 months after neonatal supplementation of a prebiotic mix: a randomized trial</article-title>. <source/>J Pediatr Gastroenterol Nutr. <year>2016</year>;<volume>63</volume>:<fpage>270</fpage>–<lpage>276</lpage>.<pub-id pub-id-type="pmid">26859091</pub-id></mixed-citation>
</ref>
<ref id="CIT0182">
<label>182.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romo-Araiza</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gutierrez-Salmean</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Galvan</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Hernandez-Frausto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Herrera-Lopez</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Romo-Parra</surname><given-names>H</given-names></name>, <name name-style="western"><surname>García-Contreras</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Fernández-Presas</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Jasso-Chávez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Borlongan</surname><given-names>CV</given-names></name>, et al</person-group>
<article-title>Probiotics and prebiotics as a therapeutic strategy to improve memory in a model of middle-aged rats</article-title>. <source/>Front Aging Neurosci. <year>2018</year>;<volume>10</volume>:<fpage>416</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2018.00416</pub-id>.<pub-id pub-id-type="pmid">30618722</pub-id></mixed-citation>
</ref>
<ref id="CIT0183">
<label>183.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajkumar</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Challa</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Nagpal</surname><given-names>R</given-names></name></person-group>
<article-title>Effect of probiotic <italic>Lactobacillus salivarius</italic> UBL S22 and prebiotic fructo-oligosaccharide on Serum Lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study</article-title>. <source/>J Cardiovasc Pharmacol Ther. <year>2015</year>;<volume>20</volume>:<fpage>289</fpage>–<lpage>298</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1074248414555004</pub-id>.<pub-id pub-id-type="pmid">25331262</pub-id></mixed-citation>
</ref>
<ref id="CIT0184">
<label>184.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Paula</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Carmuega</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Weill</surname><given-names>R</given-names></name></person-group>
<article-title>Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation</article-title>. <source/>Acta Gastroenterol Latinoam. <year>2008</year>;<volume>38</volume>:<fpage>16</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">18533353</pub-id></mixed-citation>
</ref>
<ref id="CIT0185">
<label>185.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>FAO/WHO</collab></person-group>
<source/>Expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. <publisher-loc>Córdoba (Argentina)</publisher-loc>
<month>10</month>
<year>2001</year>:<fpage>1</fpage>–<lpage>4</lpage>.</mixed-citation>
</ref>
<ref id="CIT0186">
<label>186.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kunes</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Prazienkova</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Popelova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mikulaskova</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zemenova</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Maletinska</surname><given-names>L</given-names></name></person-group>
<article-title>Prolactin-releasing peptide: a new tool for obesity treatment</article-title>. <source/>J Endocrinol. <year>2016</year>;<volume>230</volume>:<fpage>R51</fpage>–<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1530/JOE-16-0046</pub-id>.<pub-id pub-id-type="pmid">27418033</pub-id></mixed-citation>
</ref>
<ref id="CIT0187">
<label>187.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cani</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>de Vos</surname><given-names>WM</given-names></name></person-group>
<article-title>Next-generation beneficial microbes: the case of <italic>Akkermansia muciniphila</italic></article-title>. <source/>Front Microbiol. <year>2017</year>;<volume>8</volume>:<fpage>1765</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2017.01765</pub-id>.<pub-id pub-id-type="pmid">29018410</pub-id></mixed-citation>
</ref>
<ref id="CIT0188">
<label>188.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breyner</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Michon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>de Sousa</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Vilas Boas</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Chain</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Azevedo</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Langella</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chatel</surname><given-names>JM</given-names></name></person-group>
<article-title>Microbial Anti-Inflammatory Molecule (MAM) from <italic>Faecalibacterium prausnitzii</italic> shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-kappaB pathway</article-title>. <source/>Front Microbiol. <year>2017</year>;<volume>8</volume>:<fpage>114</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2017.00114</pub-id>.<pub-id pub-id-type="pmid">28203226</pub-id></mixed-citation>
</ref>
<ref id="CIT0189">
<label>189.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamady</surname><given-names>ZZ</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Farrar</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Lodge</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>KT</given-names></name>, <name name-style="western"><surname>Whitehead</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Carding</surname><given-names>SR</given-names></name></person-group>
<article-title>Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium <italic>Bacteroides ovatus</italic></article-title>. <source/>Gut. <year>2010</year>;<volume>59</volume>:<fpage>461</fpage>–<lpage>469</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gut.2008.176131</pub-id>.<pub-id pub-id-type="pmid">19736360</pub-id></mixed-citation>
</ref>
<ref id="CIT0190">
<label>190.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saarela</surname><given-names>MH</given-names></name></person-group>
<article-title>Safety aspects of next generation probiotics</article-title>. <source/>Curr Opin Food Sci. <year>2019</year>;<volume>30</volume>:<fpage>8</fpage>–<lpage>13</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cofs.2018.09.001</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0191">
<label>191.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aguilar-Toala</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Astiazaran-Garcia</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Estrada-Montoya</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Vallejo-Cordoba</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gonzalez-Cordova</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Hernández-Mendoza</surname><given-names>A</given-names></name></person-group>
<article-title>Modulatory effect of the intracellular content of <italic>Lactobacillus casei</italic> CRL 431 against the aflatoxin B1-Induced oxidative stress in rats</article-title>. <source/>Probiotics Antimicrob Proteins. 2019;11:470–477. doi:10.1007/s12602-018-9433-8.</mixed-citation>
</ref>
<ref id="CIT0192">
<label>192.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taverniti</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Guglielmetti</surname><given-names>S</given-names></name></person-group>
<article-title>The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)</article-title>. <source/>Genes Nutr. <year>2011</year>;<volume>6</volume>:<fpage>261</fpage>–<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12263-011-0218-x</pub-id>.<pub-id pub-id-type="pmid">21499799</pub-id></mixed-citation>
</ref>
<ref id="CIT0193">
<label>193.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsilingiri</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Rescigno</surname><given-names>M</given-names></name></person-group>
<article-title>Postbiotics: what else?</article-title>
<source/>Benef Microbes. <year>2013</year>;<volume>4</volume>:<fpage>101</fpage>–<lpage>107</lpage>. doi:<pub-id pub-id-type="doi">10.3920/BM2012.0046</pub-id>.<pub-id pub-id-type="pmid">23271068</pub-id></mixed-citation>
</ref>
<ref id="CIT0194">
<label>194.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>JGP</given-names></name></person-group>
<article-title>The treatment of melancholia by the lactic acid bacillus</article-title>. <source/>J Mental Sci. <year>1910</year>;<volume>56</volume>:<fpage>422</fpage>–<lpage>430</lpage>. doi:<pub-id pub-id-type="doi">10.1192/bjp.56.234.422</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0195">
<label>195.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Messaoudi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lalonde</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Violle</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Javelot</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Desor</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nejdi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bisson</surname><given-names>J-F</given-names></name>, <name name-style="western"><surname>Rougeot</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pichelin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cazaubiel</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Assessment of psychotropic-like properties of a probiotic formulation (<italic>Lactobacillus helveticus</italic> R0052 and <italic>Bifidobacterium longum</italic> R0175) in rats and human subjects</article-title>. <source/>Br J Nutr. <year>2011</year>;<volume>105</volume>:<fpage>755</fpage>–<lpage>764</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0007114510004319</pub-id>.<pub-id pub-id-type="pmid">20974015</pub-id></mixed-citation>
</ref>
<ref id="CIT0196">
<label>196.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kato-Kataoka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nishida</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Takada</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Suda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kawai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kushiro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hoshi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Igarashi</surname><given-names>T</given-names></name>, et al</person-group>
<article-title>Fermented milk containing <italic>Lactobacillus casei</italic> strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress</article-title>. <source/>Benef Microbes. <year>2016</year>;<volume>7</volume>:<fpage>153</fpage>–<lpage>156</lpage>. doi:<pub-id pub-id-type="doi">10.3920/BM2015.0100</pub-id>.<pub-id pub-id-type="pmid">26689231</pub-id></mixed-citation>
</ref>
<ref id="CIT0197">
<label>197.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slykerman</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Hood</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wickens</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>JMD</given-names></name>, <name name-style="western"><surname>Barthow</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rowden</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stone</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Crane</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>Effect of <italic>Lactobacillus rhamnosus</italic> HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: a Randomised Double-blind Placebo-controlled Trial</article-title>. <source/>EBioMedicine. <year>2017</year>;<volume>24</volume>:<fpage>159</fpage>–<lpage>165</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ebiom.2017.09.013</pub-id>.<pub-id pub-id-type="pmid">28943228</pub-id></mixed-citation>
</ref>
<ref id="CIT0198">
<label>198.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>Y</given-names></name></person-group>
<article-title>The expression of glutamate transporters in chest compression-induced audiogenic epilepsy: a comparative study</article-title>. <source/>Neurol Res. <year>2008</year>;<volume>30</volume>:<fpage>915</fpage>–<lpage>919</lpage>. doi:<pub-id pub-id-type="doi">10.1179/174313208X327964</pub-id>.<pub-id pub-id-type="pmid">18671901</pub-id></mixed-citation>
</ref>
<ref id="CIT0199">
<label>199.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarkar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lehto</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Harty</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dinan</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Cryan</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Burnet</surname><given-names>PWJ</given-names></name></person-group>
<article-title>Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals</article-title>. <source/>Trends Neurosci. <year>2016</year>;<volume>39</volume>:<fpage>763</fpage>–<lpage>781</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tins.2016.09.002</pub-id>.<pub-id pub-id-type="pmid">27793434</pub-id></mixed-citation>
</ref>
<ref id="CIT0200">
<label>200.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cassani</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Privitera</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pezzoli</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pusani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Madio</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Iorio</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Barichella</surname><given-names>M</given-names></name></person-group>
<article-title>Use of probiotics for the treatment of constipation in Parkinson’s disease patients</article-title>. <source/>Minerva Gastroenterol Dietol. <year>2011</year>;<volume>57</volume>:<fpage>117</fpage>–<lpage>121</lpage>.<pub-id pub-id-type="pmid">21587143</pub-id></mixed-citation>
</ref>
<ref id="CIT0201">
<label>201.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barichella</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pacchetti</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bolliri</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cassani</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Iorio</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pusani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pinelli</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Privitera</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cesari</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Faierman</surname><given-names>SA</given-names></name>, et al</person-group>
<article-title>Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT</article-title>. <source/>Neurology. <year>2016</year>;<volume>87</volume>:<fpage>1274</fpage>–<lpage>1280</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000003127</pub-id>.<pub-id pub-id-type="pmid">27543643</pub-id></mixed-citation>
</ref>
<ref id="CIT0202">
<label>202.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamtaji</surname><given-names>OR</given-names></name>, <name name-style="western"><surname>Taghizadeh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Daneshvar Kakhaki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kouchaki</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bahmani</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Borzabadi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Oryan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mafi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Asemi</surname><given-names>Z</given-names></name></person-group>
<article-title>Clinical and metabolic response to probiotic administration in people with Parkinson’s disease: a randomized, double-blind, placebo-controlled trial</article-title>. <source/>Clin Nutr. <year>2019</year>;<volume>38</volume>:<fpage>1031</fpage>–<lpage>1035</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clnu.2018.05.018</pub-id>.<pub-id pub-id-type="pmid">29891223</pub-id></mixed-citation>
</ref>
<ref id="CIT0203">
<label>203.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nimgampalle</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kuna</surname><given-names>Y</given-names></name></person-group>
<article-title>Anti-Alzheimer properties of probiotic, <italic>Lactobacillus plantarum</italic> MTCC 1325 in Alzheimer’s Disease induced Albino rats</article-title>. <source/>J Clin Diagn Res. <year>2017</year>;<volume>11</volume>:<fpage>KC01</fpage>–<lpage>KC5</lpage>. doi:<pub-id pub-id-type="doi">10.7860/JCDR/2017/26106.10428</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0204">
<label>204.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Athari Nik Azm</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Djazayeri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Safa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Azami</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ahmadvand</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sabbaghziarani</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sharifzadeh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vafa</surname><given-names>M</given-names></name></person-group>
<article-title>Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in beta-amyloid (1-42) injected rats</article-title>. <source/>Appl Physiol Nutr Metab. <year>2018</year>;<volume>43</volume>:<fpage>718</fpage>–<lpage>726</lpage>. doi:<pub-id pub-id-type="doi">10.1139/apnm-2017-0648</pub-id>.<pub-id pub-id-type="pmid">29462572</pub-id></mixed-citation>
</ref>
<ref id="CIT0205">
<label>205.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonfili</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cecarini</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Berardi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Scarpona</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Suchodolski</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Nasuti</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fiorini</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Boarelli</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Rossi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Eleuteri</surname><given-names>AM</given-names></name></person-group>
<article-title>Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels</article-title>. <source/>Sci Rep. <year>2017</year>;<volume>7</volume>:<fpage>2426</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-017-02587-2</pub-id>.<pub-id pub-id-type="pmid">28546539</pub-id></mixed-citation>
</ref>
<ref id="CIT0206">
<label>206.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leblhuber</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Steiner</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Schuetz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gostner</surname><given-names>JM</given-names></name></person-group>
<article-title>Probiotic Supplementation in patients with Alzheimer’s Dementia - an explorative intervention study</article-title>. <source/>Curr Alzheimer Res. <year>2018</year>;<volume>15</volume>:<fpage>1106</fpage>–<lpage>1113</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1389200219666180813144834</pub-id>.<pub-id pub-id-type="pmid">30101706</pub-id></mixed-citation>
</ref>
<ref id="CIT0207">
<label>207.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kinoshita</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Matsumoto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yoshino</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>JZ</given-names></name></person-group>
<article-title><italic>Bifidobacterium breve</italic> A1 supplementation improved cognitive decline in older adults with mild cognitive impairment: an open-label, single-arm study</article-title>. <source/>J Prev Alzheimers Dis. <year>2019</year>;<volume>6</volume>:<fpage>70</fpage>–<lpage>75</lpage>. doi:<pub-id pub-id-type="doi">10.14283/jpad.2018.32</pub-id>.<pub-id pub-id-type="pmid">30569089</pub-id></mixed-citation>
</ref>
<ref id="CIT0208">
<label>208.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akbari</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Asemi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Daneshvar Kakhaki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bahmani</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kouchaki</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tamtaji</surname><given-names>OR</given-names></name>, <name name-style="western"><surname>Hamidi</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Salami</surname><given-names>M</given-names></name></person-group>
<article-title>Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial</article-title>. <source/>Front Aging Neurosci. <year>2016</year>;<volume>8</volume>:<fpage>256</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2016.00256</pub-id>.<pub-id pub-id-type="pmid">27891089</pub-id></mixed-citation>
</ref>
<ref id="CIT0209">
<label>209.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamtaji</surname><given-names>OR</given-names></name>, <name name-style="western"><surname>Heidari-Soureshjani</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mirhosseini</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kouchaki</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bahmani</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Aghadavod</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tajabadi-Ebrahimi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Asemi</surname><given-names>Z</given-names></name></person-group>
<article-title>Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease: a randomized, double-blind, controlled trial</article-title>. <source/>Clin Nutr. <year>2018</year>. doi:<pub-id pub-id-type="doi">10.1016/j.clnu.2018.11.034</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0210">
<label>210.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staley</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Khoruts</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sadowsky</surname><given-names>MJ</given-names></name></person-group>
<article-title>Contemporary applications of fecal microbiota transplantation to treat intestinal diseases in humans</article-title>. <source/>Arch Med Res. <year>2017</year>;<volume>48</volume>:<fpage>766</fpage>–<lpage>773</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arcmed.2017.11.006</pub-id>.<pub-id pub-id-type="pmid">29183720</pub-id></mixed-citation>
</ref>
<ref id="CIT0211">
<label>211.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>G</given-names></name></person-group>
<article-title>Should we standardize the 1,700-year-old fecal microbiota transplantation?</article-title>
<source/>Am J Gastroenterol. <year>2012</year>;<volume>107</volume>:<fpage>1755</fpage>
<comment>author reply p −6</comment>. doi:<pub-id pub-id-type="doi">10.1038/ajg.2012.251</pub-id>.<pub-id pub-id-type="pmid">23160295</pub-id></mixed-citation>
</ref>
<ref id="CIT0212">
<label>212.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakken</surname><given-names>JS</given-names></name></person-group>
<article-title>Fecal bacteriotherapy for recurrent <italic>Clostridium difficile infection</italic></article-title>. <source/>Anaerobe. <year>2009</year>;<volume>15</volume>:<fpage>285</fpage>–<lpage>289</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.anaerobe.2009.09.007</pub-id>.<pub-id pub-id-type="pmid">19778623</pub-id></mixed-citation>
</ref>
<ref id="CIT0213">
<label>213.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moayyedi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Surette</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>PT</given-names></name>, <name name-style="western"><surname>Libertucci</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wolfe</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Onischi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Armstrong</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Kassam</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Reinisch</surname><given-names>W</given-names></name>, et al</person-group>
<article-title>Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial</article-title>. <source/>Gastroenterology. <year>2015</year>;<volume>149</volume>:<fpage>102</fpage>–<lpage>9 e6</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2015.04.001</pub-id>.<pub-id pub-id-type="pmid">25857665</pub-id></mixed-citation>
</ref>
<ref id="CIT0214">
<label>214.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmulson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bashashati</surname><given-names>M</given-names></name></person-group>
<article-title>Fecal microbiota transfer for bowel disorders: efficacy or hype?</article-title>
<source/>Curr Opin Pharmacol. <year>2018</year>;<volume>43</volume>:<fpage>72</fpage>–<lpage>80</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.coph.2018.08.012</pub-id>.<pub-id pub-id-type="pmid">30218939</pub-id></mixed-citation>
</ref>
<ref id="CIT0215">
<label>215.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bercik</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Denou</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jury</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Blennerhassett</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Macri</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McCoy</surname><given-names>KD</given-names></name>, et al</person-group>
<article-title>The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice</article-title>. <source/>Gastroenterology. <year>2011</year>;<volume>141</volume>(<issue>599–609</issue>):<fpage>e1</fpage>–<lpage>3</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2011.04.052</pub-id>.</mixed-citation>
</ref>
<ref id="CIT0216">
<label>216.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>X</given-names></name>, et al</person-group>
<article-title>Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism</article-title>. <source/>Mol Psychiatry. <year>2016</year>;<volume>21</volume>:<fpage>786</fpage>–<lpage>796</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2016.44</pub-id>.<pub-id pub-id-type="pmid">27067014</pub-id></mixed-citation>
</ref>
<ref id="CIT0217">
<label>217.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Borre</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>OB</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>El Aidy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Deane</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Beers</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Moloney</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat</article-title>. <source/>J Psychiatr Res. <year>2016</year>;<volume>82</volume>:<fpage>109</fpage>–<lpage>118</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.07.019</pub-id>.<pub-id pub-id-type="pmid">27491067</pub-id></mixed-citation>
</ref>
<ref id="CIT0218">
<label>218.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McFarlane</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Kusek</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Phoenix</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Bolivar</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Crawley</surname><given-names>JN</given-names></name></person-group>
<article-title>Autism-like behavioral phenotypes in BTBR T+tf/J mice</article-title>. <source/>Genes Brain Behav. <year>2008</year>;<volume>7</volume>:<fpage>152</fpage>–<lpage>163</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1601-183X.2007.00330.x</pub-id>.<pub-id pub-id-type="pmid">17559418</pub-id></mixed-citation>
</ref>
<ref id="CIT0219">
<label>219.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarcz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Muchowski</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>HQ</given-names></name></person-group>
<article-title>Kynurenines in the mammalian brain: when physiology meets pathology</article-title>. <source/>Nat Rev Neurosci. <year>2012</year>;<volume>13</volume>:<fpage>465</fpage>–<lpage>477</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn3257</pub-id>.<pub-id pub-id-type="pmid">22678511</pub-id></mixed-citation>
</ref>
<ref id="CIT0220">
<label>220.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>ZL</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>XB</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>YD</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>Y-Q</given-names></name></person-group>
<article-title>Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: gut microbiota, glial reaction and TLR4/TNF-alpha signaling pathway</article-title>. <source/>Brain Behav Immun. <year>2018</year>;<volume>70</volume>:<fpage>48</fpage>–<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2018.02.005</pub-id>.<pub-id pub-id-type="pmid">29471030</pub-id></mixed-citation>
</ref>
<ref id="CIT0221">
<label>221.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ananthaswamy</surname><given-names>A</given-names></name></person-group>
<source/>Faecal transplant eases symptoms of Parkinson’s disease. <publisher-name>Elsevier</publisher-name>, <year>2011</year>.</mixed-citation>
</ref>
<ref id="CIT0222">
<label>222.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woodworth</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Carpentieri</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sitchenko</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Kraft</surname><given-names>CS</given-names></name></person-group>
<article-title>Challenges in fecal donor selection and screening for fecal microbiota transplantation: a review</article-title>. <source/>Gut Microbes. <year>2017</year>;<volume>8</volume>:<fpage>225</fpage>–<lpage>237</lpage>. doi:<pub-id pub-id-type="doi">10.1080/19490976.2017.1286006</pub-id>.<pub-id pub-id-type="pmid">28129018</pub-id></mixed-citation>
</ref>
<ref id="CIT0223">
<label>223.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Willemsen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Popkes</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Metge</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gandiwa</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Reichard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Valenzano</surname><given-names>DR</given-names></name></person-group>
<article-title>Regulation of life span by the gut microbiota in the short-lived African turquoise killifish</article-title>. <source/>Elife. <year>2017</year>;<volume>6:e27014. doi:10.7554/eLife.27014</volume>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>